Processing 00000000.tx.1: Phenotyping of Individual Pancreatic Islets Locates Genetic Defects in Stimulus Secretion Coupling to Niddm1i Within the Major Diabetes Locus in GK Rats Jian-Man Lin1, Henrik Ortster1, Hossein Fakhrai-Rad2, Joakim Galli2, Holger Luthman2, and Peter Bergsten1 1 Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden 2 Karolinska Institute, Center for Molecular Medicine, Department of Molecular Medicine, Karolinska Hospital, Stockholm, Sweden  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  The major diabetes quantitative trait locus (Niddm1), which segregates in crosses between GK rats affected with spontaneous type 2like diabetes and normoglycemic F344 rats, encodes at least two different diabetes susceptibility genes. 

Phrase: "Phenotyping of Individual Pancreatic Islets"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1285572:Phenotyping [Laboratory Procedure]
   760   C1314763:Phenotyping [Functional Concept]
   726 E C0031437:Phenotype [Organism Attribute]

Phrase: "Locates"

Phrase: "Genetic Defects in Stimulus Secretion Coupling"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   762   C0000768:Birth Defects [Congenital Abnormality]
   762   C0220810:birth defects [Functional Concept]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0243067:defects [Functional Concept]
   753   C0314603:Genetic [Functional Concept]
   745 E C1737329:Birth defect [Congenital Abnormality]
   742   C0487949:genital secretion [Body Substance]
   719 E C1457869:Defect [Functional Concept]
   719 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "to Niddm1i"

Phrase: "Within the Major Diabetes Locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "in GK Rats Jian-Man Lin1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1413217:LIN1 [Gene or Genome]

Phrase: "Henrik Ortster1,"

Phrase: "Hossein Fakhrai-Rad2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3273832:RAD2 [Gene or Genome]

Phrase: "Joakim Galli2,"

Phrase: "Holger Luthman2,"

Phrase: "and"

Phrase: "Peter Bergsten1 1 Department of Medical Cell Biology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0587450:Medical department [Health Care Related Organization]
   744   C1704729:Department [Organization]

Phrase: "Uppsala University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Uppsala,"

Phrase: "Sweden 2 Karolinska Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]

Phrase: "Center for Molecular Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "Department of Molecular Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Karolinska Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Stockholm,"

Phrase: "Sweden  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0035171:Research Design [Research Activity]
   795   C0035168:research [Research Activity]
   795   C0242481:Research [Research Activity]
   795   C1707689:Design [Activity]
   795   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The major diabetes quantitative trait locus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0597336:quantitative trait locus [Gene or Genome]
   804   C0392762:Quantitative [Quantitative Concept]
   804   C0599883:Trait [Organism Attribute]
   804   C1708726:Locus [Gene or Genome]

Phrase: "(Niddm1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417726:NIDDM1 [Gene or Genome]
  1000   C1832544:NIDDM1 [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "segregates in crosses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C2828360:Cross [Conceptual Entity]

Phrase: "between GK rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "affected with spontaneous type 2like diabetes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   783   C1320657:Diabetes type [Finding]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0205359:Spontaneous [Functional Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0392760:Affected [Functional Concept]
   753   C1314939:Affected [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   719 E C0001721:Affect [Mental Process]

Phrase: "and"

Phrase: "normoglycemic F344 rats,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034703:Rats, F344 [Mammal]
           F344
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "encodes at least two different diabetes susceptibility genes."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   754   C0919453:Susceptibility Gene [Gene or Genome]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0012655:Susceptibility [Clinical Attribute]
   744   C0017337:Genes [Gene or Genome]
   744   C0205448:Two [Quantitative Concept]
   744   C0220898:Susceptibility [Organism Attribute]
   744   C1264642:Susceptibility [Functional Concept]
   744   C1547045:*Susceptibility [Quantitative Concept]
   744   C1705242:Different [Qualitative Concept]
   744   C2700640:Encode [Activity]
Processing 00000000.tx.2: Congenic strains for the two subloci (Niddm1f and Niddm1i) have been generated by transfer of GK alleles onto the genome of F344 rats. 

Phrase: "Congenic strains for the two subloci"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   773   C1516786:Congenic Strain [Animal]
   753   C0080194:Strains [Injury or Poisoning]
   753   C0456178:strains [Intellectual Product]
   719 E C1518614:Strain [Organism]
   719 E C2987481:Strain [Mental Process]

Phrase: "(Niddm1f"

Phrase: "and"

Phrase: "Niddm1i"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "generated by transfer of GK alleles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0002085:Alleles [Gene or Genome]
   753   C0040671:Transfer [Mental Process]
   753   C1705822:Transfer [Activity]
   753   C3146294:Generated [Activity]

Phrase: "onto the genome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017428:Genome [Gene or Genome]
  1000   C2338314:Genome [Conceptual Entity]

Phrase: "of F344 rats."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034703:Rats, F344 [Mammal]
           F344
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.3: Whereas the Niddm1f phenotype implicated insulin resistance, the Niddm1i phenotype displayed diabetes related to insulin deficiency. 

Phrase: "Whereas"

Phrase: "the Niddm1f phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "implicated"

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "the Niddm1i phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "related to insulin deficiency."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0011155:Deficiency [Functional Concept]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0162429:Deficiency [Disease or Syndrome]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1623416:deficiency [Qualitative Concept]
   737 E C0163712:Relate [Organic Chemical]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.4: Individual islets from 16-week-old congenic rats were characterized for insulin release and oxygen tension (pO2). 

Phrase: "Individual islets from 16-week-old congenic rats"

Phrase: "were"

Phrase: "characterized for insulin release"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1880022:Characterized [Activity]
   770   C1963578:Release [Therapeutic or Preventive Procedure]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "oxygen tension"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0202155:oxygen tension [Laboratory Procedure]
  1000   C1536627:oxygen tension [Physiologic Function]
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0233494:Tension [Mental or Behavioral Dysfunction]

Phrase: "(pO2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0202155:pO2 [Laboratory Procedure]
  1000   C1283004:PO2 [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.5: In the presence of 3 mmol/l glucose, insulin release from Niddm1f and Niddm1i islets was 5 pmol  g-1  s-1 and pO2 was 120 mmHg. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 3 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "insulin release from Niddm1f"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1963578:Release [Therapeutic or Preventive Procedure]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "Niddm1i islets"

Phrase: "was"

Phrase: "5 pmol  g-1  s-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   898   C3202978:5-1-1 [Qualitative Concept]
   839   C0086903:G S [Amino Acid, Peptide, or Protein,Enzyme]
   839   C2827790:g/s [Quantitative Concept]

Phrase: "and"

Phrase: "pO2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0202155:pO2 [Laboratory Procedure]
  1000   C1283004:PO2 [Laboratory Procedure]

Phrase: "was"

Phrase: "120 mmHg."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439475:mmHg [Quantitative Concept]
Processing 00000000.tx.6: Similar recordings were obtained from GK and F344 islets. 

Phrase: "Similar recordings"

Phrase: "were"

Phrase: "obtained from GK"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "F344 islets."
Processing 00000000.tx.7: When glucose was raised to 11 mmol/l, insulin release increased significantly in Niddm1f and F344 islets but was essentially unchanged in islets from GK and Niddm1i. 

Phrase: "When"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "raised to 11 mmol/l,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1532563:mmol/L [Quantitative Concept]
   760   C0439190:MMOLE [Quantitative Concept]
   760   C0442818:Raised [Quantitative Concept]

Phrase: "insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "significantly in Niddm1f"

Phrase: "and"

Phrase: "F344 islets"

Phrase: "but"

Phrase: "was"

Phrase: "essentially unchanged in islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442739:Unchanged [Finding]
   770   C2346711:Unchanged [Qualitative Concept]

Phrase: "from GK"

Phrase: "and"

Phrase: "Niddm1i."
Processing 00000000.tx.8: The high glucose concentration lowered pO2 to the same extent in islets from all strains. 

Phrase: "The high glucose concentration"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0860803:high glucose [Finding]

Phrase: "lowered"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0441994:lowered [Spatial Concept]
  1000   C1272755:Lowered [Quantitative Concept]
  1000   C2003888:Lowered [Activity]
   966 E C1548802:Lower [Body Location or Region]

Phrase: "pO2 to the same extent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0202155:pO2 [Laboratory Procedure]
   760   C1283004:PO2 [Laboratory Procedure]

Phrase: "in islets"

Phrase: "from all strains."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0080194:Strains [Injury or Poisoning]
  1000   C0456178:strains [Intellectual Product]
   966 E C1518614:Strain [Organism]
   966 E C2987481:Strain [Mental Process]
Processing 00000000.tx.9: Addition of 1 mmol/l tolbutamide to the perifusion medium further increased pulsatile insulin release threefold in all islets. 

Phrase: "Addition of 1 mmol/l tolbutamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]

Phrase: "to the perifusion medium further increased pulsatile insulin release"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   829   C0020459:increased insulin [Disease or Syndrome]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0030685:Release [Health Care Activity]
   795   C0391871:Release [Functional Concept]
   795   C0439180:% release [Quantitative Concept]
   795   C0680255:release [Health Care Activity]
   795   C1283071:Release [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1963578:Release [Therapeutic or Preventive Procedure]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "threefold in all islets."
Processing 00000000.tx.10: The pulse frequency was 0.4 min-1. 

Phrase: "The pulse frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "was"

Phrase: "0.4 min-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1301862:Min 1 [Temporal Concept]
   812   C0702093:/min [Temporal Concept]
Processing 00000000.tx.11: -Ketoisocaproate (11 mmol/l) alone increased pulsatile insulin release eightfold in islets from Niddm1f, Niddm1i, and control F344 rats but had no effect on insulin release from GK islets. 

Phrase: "-Ketoisocaproate"

Phrase: "(11 mmol/l) alone increased pulsatile insulin release"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   822   C0020459:increased insulin [Disease or Syndrome]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0030685:Release [Health Care Activity]
   793   C0391871:Release [Functional Concept]
   793   C0439180:% release [Quantitative Concept]
   793   C0680255:release [Health Care Activity]
   793   C1283071:Release [Functional Concept]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   793   C1963578:Release [Therapeutic or Preventive Procedure]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "eightfold in islets"

Phrase: "from Niddm1f,"

Phrase: "Niddm1i,"

Phrase: "and"

Phrase: "control F344 rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034703:Rats, F344 [Mammal]
           F344
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "but"

Phrase: "had"

Phrase: "no effect on insulin release"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "from GK islets."
Processing 00000000.tx.12: These secretory patterns in response to -ketoisocaproate were paralleled by reduction of pO2 in Niddm1f, Niddm1i, and control F344 islets and no change of pO2 in GK islets. 

Phrase: "These secretory patterns in response to -ketoisocaproate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "paralleled by reduction of pO2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0202155:pO2 [Laboratory Procedure]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   760   C1283004:PO2 [Laboratory Procedure]
   726   C2348042:Parallel [Qualitative Concept]
   726   C2826345:PARALLEL [Research Activity]

Phrase: "in Niddm1f,"

Phrase: "Niddm1i,"

Phrase: "and"

Phrase: "control F344 islets"

Phrase: "and"

Phrase: "no change of pO2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0442739:No change [Finding]
   833   C1548568:No change [Intellectual Product]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "in GK islets."
Processing 00000000.tx.13: The results demonstrate that Niddm1i carries alleles of gene(s) that reduce glucose-induced insulin release and that are amenable to molecular identification by genetic fine mapping.  

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that Niddm1i"

Phrase: "carries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:Carries [Finding]

Phrase: "alleles of gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0002085:Alleles [Gene or Genome]

Phrase: "("

Phrase: "s)"

Phrase: "that"

Phrase: "reduce"

Phrase: "glucose-induced insulin release"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1963578:Release [Therapeutic or Preventive Procedure]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "that"

Phrase: "are"

Phrase: "amenable to molecular identification"

Phrase: "by genetic fine mapping."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0008630:genetic mapping [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1283195:Mapping [Activity]
Processing 00000000.tx.14: INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Type 2 diabetes is a multifactorial disease that is influenced by environmental and genetic factors (1,2,3). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "a multifactorial disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "that"

Phrase: "is"

Phrase: "influenced by environmental"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0014406:Environmental [Spatial Concept]

Phrase: "and"

Phrase: "genetic factors"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: The disease is a heterogeneous metabolic disorder characterized by impairment of insulin secretion from pancreatic -cells and insulin resistance in peripheral tissues (4,5). 

Phrase: "The disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "a heterogeneous metabolic disorder"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1858576:Heterogeneous disorder [Finding]
   901   C0025517:Metabolic disorder [Disease or Syndrome]
   827   C0012634:Disorder [Disease or Syndrome]

Phrase: "characterized by impairment of insulin secretion"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1256369:insulin secretion [Cell Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0684336:Impairment [Pathologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1880022:Characterized [Activity]

Phrase: "from pancreatic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "insulin resistance in peripheral tissues"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   797   C1258192:Peripheral Resistance [Physiologic Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.16: For identifying genes and new mechanisms relevant to the pathophysiology of the disease, genetic dissection of animal models has been initiated (6,7,8,9,10,11,12,13). 

Phrase: "For identifying genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "new mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "relevant to the pathophysiology of the disease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347946:Relevant [Qualitative Concept]

Phrase: "genetic dissection of animal models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012737:Dissection [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "(6,"

Phrase: "7,"

Phrase: "8,"

Phrase: "9,"

Phrase: "10,"

Phrase: "11,"

Phrase: "12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.17: In the GK rat, which has defects in both insulin secretion and action and demonstrates late complications characteristic of the disease (14,15,16), genetic analysis identified several quantitative trait loci (QTLs), some with genome-wide significance for diabetes-associated phenotypes (6,7). 

Phrase: "In the GK rat,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]

Phrase: "which"

Phrase: "has"

Phrase: "defects in both insulin secretion"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0243067:defects [Functional Concept]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]

Phrase: "and"

Phrase: "demonstrates"

Phrase: "late complications"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009566:Complications [Pathologic Function]
   861   C1171258:complications [Pathologic Function]
   827 E C2362589:Complication [Idea or Concept]
   777 E C0231242:Complicated [Functional Concept]

Phrase: "characteristic of the disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0599878:disease characteristic [Pathologic Function]
   770   C1521970:Characteristic [Qualitative Concept]

Phrase: "(14,"

Phrase: "15,"

Phrase: "16"

Phrase: ")"

Phrase: ","

Phrase: "genetic analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0679560:genetic analysis [Laboratory Procedure]
  1000   C0796344:Genetic Analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "several quantitative trait loci (QTLs),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0597336:Quantitative Trait Loci [Gene or Genome]
   812   C0392762:Quantitative [Quantitative Concept]
   812   C0599883:Trait [Organism Attribute]
   779   C1708726:Locus [Gene or Genome]

Phrase: "some with genome-wide significance"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0017428:Genome [Gene or Genome]
   760   C0205392:Some [Quantitative Concept]
   760   C0237881:Significance [Quantitative Concept]
   760   C0332464:Wide [Spatial Concept]
   760   C0750502:Significance [Idea or Concept]
   760   C2338314:Genome [Conceptual Entity]
   760   C3540770:Some [Intellectual Product]

Phrase: "for diabetes-associated phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0031437:Phenotypes [Organism Attribute]
   793 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.18: For further characterization of the major GK-diabetes QTL, Niddm1, congenic strains were established by introgression of the Niddm1 locus onto the genome of the normoglycemic F344 rat. 

Phrase: "For further characterization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880022:Characterization [Activity]

Phrase: "of the major GK-diabetes QTL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597336:QTL [Gene or Genome]

Phrase: "Niddm1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417726:NIDDM1 [Gene or Genome]
  1000   C1832544:NIDDM1 [Disease or Syndrome]

Phrase: "congenic strains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C1516786:Congenic Strain [Animal]
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]

Phrase: "were"

Phrase: "established by introgression of the Niddm1 locus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0443211:Established [Qualitative Concept]
   748   C1272684:Established [Qualitative Concept]
   748   C1417726:NIDDM1 [Gene or Genome]
   748   C1708726:Locus [Gene or Genome]
   748   C1832544:NIDDM1 [Disease or Syndrome]

Phrase: "onto the genome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017428:Genome [Gene or Genome]
  1000   C2338314:Genome [Conceptual Entity]

Phrase: "of the normoglycemic F344 rat."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034703:Rat, F344 [Mammal]
           F344
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
Processing 00000000.tx.19: By genetic and pathophysiological characterization of the Niddm1 congenic strains, the locus was divided into two subloci, physically separated in the congenic strains Niddm1b and Niddm1i with distinct metabolic phenotypes (17). 

Phrase: "By genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "pathophysiological characterization of the Niddm1 congenic strains,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]

Phrase: "the locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708726:Locus [Gene or Genome]

Phrase: "was"

Phrase: "divided into two subloci,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205448:Two [Quantitative Concept]
   770   C0332849:Divided [Functional Concept]

Phrase: "physically"

Phrase: "separated in the congenic strains Niddm1b"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   773   C1516786:Congenic Strain [Animal]
   753   C0080194:Strains [Injury or Poisoning]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0456178:strains [Intellectual Product]
   753   C0687118:Separated [Functional Concept]
   719 E C1518614:Strain [Organism]
   719 E C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "Niddm1i with distinct metabolic phenotypes"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.20: Both strains displayed postprandial hyperglycemia and reduced insulin action in isolated adipose cells. 

Phrase: "Both"

Phrase: "strains"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]
   944 E C0180860:Filter [Manufactured Object]
   944 E C0581406:Filter [Medical Device]
   944 E C1522664:Filter [Intellectual Product]
   944 E C1704449:Filter [Conceptual Entity]
   944 E C1704684:Filter [Medical Device]
   944 E C1875155:FILTER [Medical Device]
   916 E C0442694:Straining [Physiologic Function]

Phrase: "displayed postprandial hyperglycemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1855520:Hyperglycemia, Postprandial [Finding]
   827   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "reduced insulin action in isolated adipose cells."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C0030281:Insulin Cell [Cell]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0441472:Action [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C3266814:Action [Activity]
Processing 00000000.tx.21: Relatively early in life, an insulin secretory defect was suggested in Niddm1i by the decreased serum insulin levels despite hyperglycemia after glucose challenge. 

Phrase: "Relatively early in life,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0376558:Life [Idea or Concept]
   812   C1279919:Early [Temporal Concept]
   729 E C0595998:lives [Finding]

Phrase: "an insulin secretory defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1457869:Defect [Functional Concept]
   827   C1861101:DEFECT [Disease or Syndrome]

Phrase: "was"

Phrase: "suggested in Niddm1i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1705535:Suggest [Idea or Concept]

Phrase: "by the decreased serum insulin levels"
Meta Candidates (Total=19; Excluded=5; Pruned=0; Remaining=14)
   906   C1295676:Decreased insulin level [Finding]
   890   C0428357:Serum insulin level [Laboratory Procedure]
           Serum insulin
   890   C1261415:serum insulin level [Laboratory or Test Result]
           serum insulin
   861   C0202098:insulin levels [Laboratory Procedure]
   861   C0428405:insulin levels [Laboratory or Test Result]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0229671:Serum [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "despite hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "after glucose challenge."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.22: Niddm1b also displayed a relative insulin secretory defect later in life, but the phenotype of Niddm1b indicated that the primary defect is in insulin action, rather than in insulin secretion (17,18). 

Phrase: "Niddm1b also"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a relative insulin secretory defect later in life,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0376558:Life [Idea or Concept]
   712 E C0595998:lives [Finding]

Phrase: "but"

Phrase: "the phenotype of Niddm1b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031437:Phenotype [Organism Attribute]
   770   C1285572:Phenotype [Laboratory Procedure]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the primary defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1457869:Defect [Functional Concept]
   861   C1861101:DEFECT [Disease or Syndrome]

Phrase: "is in insulin action,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0441472:Action [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C3266814:Action [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "rather than in insulin secretion"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.23: To further characterize the difference in insulin secretion phenotype between the two subloci of Niddm1, we investigated the kinetics of insulin release and oxygen tension (pO2). 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "characterize"

Phrase: "the difference in insulin secretion phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "between the two subloci"

Phrase: "of Niddm1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417726:NIDDM1 [Gene or Genome]
  1000   C1832544:NIDDM1 [Disease or Syndrome]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the kinetics of insulin release"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0022702:Kinetics [Natural Phenomenon or Process]
   760   C0220865:kinetics [Functional Concept]
   760   C2825046:Kinetics [Occupation or Discipline]

Phrase: "and"

Phrase: "oxygen tension"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0202155:oxygen tension [Laboratory Procedure]
  1000   C1536627:oxygen tension [Physiologic Function]
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0233494:Tension [Mental or Behavioral Dysfunction]

Phrase: "(pO2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0202155:pO2 [Laboratory Procedure]
  1000   C1283004:PO2 [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.24: The measurements were performed in islets from Niddm1i and Niddm1f, which is a subline of Niddm1b (18), in response to changes in the concentrations of glucose, tolbutamide, and -ketoisocaproate (KIC). 

Phrase: "The measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "performed in islets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from Niddm1i"

Phrase: "and"

Phrase: "Niddm1f,"

Phrase: "which"

Phrase: "is"

Phrase: "a subline of Niddm1b"

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in the concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "tolbutamide,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   944 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]

Phrase: "and -"

Phrase: "ketoisocaproate (KIC)."
Processing 00000000.tx.25: The results showed a secretory defect in response to glucose linked to the Niddm1i locus.  

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a secretory defect in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "linked to the Niddm1i locus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1708726:Locus [Gene or Genome]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
Processing 00000000.tx.26: RESEARCH DESIGN AND METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Materials. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C0086912:methods research [Research Activity]
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]
Processing 00000000.tx.27: Reagents of analytical grade and deionized water were used. 

Phrase: "Reagents of analytical grade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "deionized water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.28: Collagenase, HEPES, and bovine serum albumin (BSA; fraction V) were obtained from Boehringer Mannheim (Mannheim, Germany). 

Phrase: "Collagenase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "(BSA"

Phrase: "; fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "V)"

Phrase: "were"

Phrase: "obtained from Boehringer Mannheim"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "(Mannheim,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.29: Tetramethylbenzidine, insulin-peroxidase, and KIC were bought from Sigma (St. Louis, MO). 

Phrase: "Tetramethylbenzidine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0046880:Tetramethylbenzidine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "insulin-peroxidase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "KIC"

Phrase: "were"

Phrase: "bought from Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1719918:Sigma [Intellectual Product]

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.30: The rat insulin standard was from Novo Nordisk (Bagsvaerd, Denmark). 

Phrase: "The rat insulin standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1442989:Standard [Qualitative Concept]
   827   C2828392:Standard [Intellectual Product]

Phrase: "was from Novo Nordisk"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0331875:Novo Nordisk [Health Care Related Organization]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]

Phrase: "(Bagsvaerd,"

Phrase: "Denmark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011318:Denmark [Geographic Area]

Phrase: ")."
Processing 00000000.tx.31: IgG-certified microtiter plates were purchased from Nunc (Roskilde, Denmark). 

Phrase: "IgG-certified microtiter plates"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C1709027:Microtiter Plate [Research Device]
   812   C1139930:plates [Medical Device]
   779 E C0005971:Plate [Medical Device]
   779 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "purchased from Nunc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(Roskilde,"

Phrase: "Denmark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011318:Denmark [Geographic Area]

Phrase: ")."
Processing 00000000.tx.32: Tolbutamide was a gift from Hoechst (Frankfurt, Germany). 

Phrase: "Tolbutamide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   944 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "a gift from Hoechst"

Phrase: "(Frankfurt,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.33: The mouse insulin antibodies were raised in our laboratory from guinea pigs. 

Phrase: "The mouse insulin antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0021644:Insulin Antibodies [Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "raised in our laboratory"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C0442818:Raised [Quantitative Concept]
   770   C3244292:laboratory [Functional Concept]

Phrase: "from guinea pigs."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0085979:Guinea Pigs [Mammal]
   966 E C0999699:Guinea-pig [Mammal]
   861   C0018381:Guinea [Geographic Area]
   861   C0039005:Pigs [Mammal]
   861   C1135183:pigs [Mammal]
   861   C2828412:Guinea [Reptile]
   827 E C1136016:PIG [Mammal]
   827 E C1265533:Pig [Mammal]
   827 E C1270360:Pig [Mammal]
Processing 00000000.tx.34: Animals. 

Phrase: "Animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]
Processing 00000000.tx.35: GK and F344 rats were obtained and bred as described previously (17,18). 

Phrase: "GK"

Phrase: "and"

Phrase: "F344 rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034703:Rats, F344 [Mammal]
           F344
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "bred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0006159:breed [Organism Function]
   966   C1704650:Breed [Classification]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.36: GK-derived genetic intervals were transferred onto the F344 background by 10 successive backcrosses followed by intercrosses between heterozygous animals to establish homozygous congenic strains. 

Phrase: "GK-derived genetic intervals"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0005605:Birth Intervals [Temporal Concept]
   812   C1272706:intervals [Temporal Concept]
   779 E C1552654:Interval [Idea or Concept]
   779 E C1552713:Interval [Intellectual Product]

Phrase: "were"

Phrase: "transferred onto the F344 background"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0034703:F344 [Mammal]
   760   C0348011:transferred [Functional Concept]
   760   C1706907:Background [Conceptual Entity]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "by 10 successive backcrosses"

Phrase: "followed by intercrosses"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "between heterozygous animals to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "homozygous congenic strains."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   884   C1516786:Congenic Strain [Animal]
   827   C0080194:Strains [Injury or Poisoning]
   827   C0456178:strains [Intellectual Product]
   793 E C1518614:Strain [Organism]
   793 E C2987481:Strain [Mental Process]
Processing 00000000.tx.37: At each generation, genetic markers from the Niddm1 region were used to verify the integrity of the GK-susceptibility haplotype. 

Phrase: "At each generation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "genetic markers from the Niddm1 region"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0017393:Genetic Markers [Genetic Function]
   790   C0600223:genetic markers [Laboratory Procedure]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0314603:Genetic [Functional Concept]
   742   C0446509:Genital region [Body Location or Region]
   719   C0005516:Marker [Clinical Attribute]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "the integrity of the GK-susceptibility haplotype."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205266:integrity [Qualitative Concept]
   748   C0872403:integrity [Individual Behavior]
   748   C1947912:Integrity [Qualitative Concept]
Processing 00000000.tx.38: The GK-derived chromosome regions are 7.6  1 cM in Niddm1f (defined by the markers D1Mit7 and D1Mgh25) and 22  1 cM in Niddm1i (defined by the markers D1Arb42a and D1Rat90). 

Phrase: "The GK-derived chromosome regions"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   844   C1953345:Chromosome region [Cell]
   779   C0017446:Region [Geographic Area]
   779   C0205147:Region [Spatial Concept]
   729 E C0205276:Regional [Spatial Concept]
   729 E C1947913:Regional [Spatial Concept]

Phrase: "are"

Phrase: "7.6  1 cM in Niddm1f"

Phrase: "("

Phrase: "defined by the markers D1Mit7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]
   726   C0005516:Marker [Clinical Attribute]

Phrase: "and"

Phrase: "D1Mgh25"

Phrase: ")"

Phrase: "and"

Phrase: "22  1 cM in Niddm1i"

Phrase: "("

Phrase: "defined by the markers D1Arb42a"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]
   726   C0005516:Marker [Clinical Attribute]

Phrase: "and"

Phrase: "D1Rat90"

Phrase: ")."
Processing 00000000.tx.39: General design of experiments. 

Phrase: "General design of experiments."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   802   C0035171:Experiment Design [Research Activity]
   777 E C0015320:Experimental Design [Research Activity]
   770   C1707689:Design [Activity]
   770   C2983265:DESIGN [Intellectual Product]
Processing 00000000.tx.40: Pancreatic islets were isolated from male Niddm1f, Niddm1i, and GK rats aged 16 weeks by shaking excised and minced pancreata in a buffer containing collagenase (6.7 mg/ml) at 37C for 15 min. 

Phrase: "Pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "isolated from male Niddm1f,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0024554:Male [Finding]
   770   C0086582:male [Population Group]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1706180:Male [Qualitative Concept]
   770   C1706428:Male [Qualitative Concept]
   770   C1706429:Male [Organism Attribute]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "Niddm1i,"

Phrase: "and"

Phrase: "GK rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "16 weeks by shaking"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439230:weeks [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]

Phrase: "excised"

Phrase: "and"

Phrase: "minced pancreata in a buffer containing collagenase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   714   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "(6.7 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml) at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439526:/mL [Quantitative Concept]

Phrase: "for 15 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.41: Age-matched male F344 rats were used as controls. 

Phrase: "Age-matched male F344 rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0034703:Rats, F344 [Mammal]
           F344
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "used as controls."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.42: Islets were cultured for 24 h in RPMI 1640 medium supplemented with 10% fetal calf serum, 100 IU/ml penicillin, and 5.5 mmol/l glucose. 

Phrase: "Islets"

Phrase: "were"

Phrase: "cultured for 24 h"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "in RPMI 1640 medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 10% fetal calf serum,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "100 IU/ml penicillin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]
   756   C2346524:100 IU/mL [Quantitative Concept]

Phrase: "and"

Phrase: "5.5 mmol/l glucose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]
Processing 00000000.tx.43: Perifusion of the islets for insulin and oxygen tension measurements was performed in a medium containing 1 mg/ml BSA and (in mmol/l): NaCl 125, KCl 5.9, MgCl2 1.2, CaCl2 1.28, and HEPES 25, titrated to pH 7.4 with NaOH. 

Phrase: "Perifusion of the islets"

Phrase: "for insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "oxygen tension measurements"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C0523806:Oxygen measurement [Laboratory Procedure]
   827   C0242485:measurements [Functional Concept]
   734   C0202155:oxygen tension [Laboratory Procedure]
   734   C1536627:oxygen tension [Physiologic Function]

Phrase: "was"

Phrase: "performed in a medium containing 1 mg/ml BSA"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   764   C0439294:mg ml [Quantitative Concept]
   742   C0009458:Medium [Intellectual Product]
   742   C0332256:Containing [Functional Concept]
   742   C0439269:mg% [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C0439536:Medium [Quantitative Concept]
   742   C0884358:Performed [Functional Concept]
   742   C1705217:Medium [Substance]
   742   C1960952:mg % [Quantitative Concept]
   742   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C2700400:Containing [Activity]
   742   C3244283:medium [Intellectual Product]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and (in mmol/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439190:MMOLE [Quantitative Concept]
   790   C1515981:And [Idea or Concept]

Phrase: "l)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: ":"

Phrase: "NaCl 125,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "KCl 5.9,"

Phrase: "MgCl2 1.2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "CaCl2 1.28,"

Phrase: "and"

Phrase: "HEPES 25,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "titrated to pH 7.4"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1882074:pH 7 [Qualitative Concept]
   797   C2678549:PH-4 [Gene or Genome]
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
   726   C1883350:Titrate [Health Care Activity]

Phrase: "with NaOH."
Processing 00000000.tx.44: Glucose, tolbutamide, and KIC were added to the perifusion medium in concentrations indicated in the tables and figures. 

Phrase: "Glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "tolbutamide,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   944 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "KIC"

Phrase: "were"

Phrase: "added to the perifusion medium"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1524062:Added [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726 E C1883712:Add [Functional Concept]

Phrase: "in concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "indicated in the tables"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0039224:tables [Manufactured Object]
   770   C1444656:Indicated [Finding]
   770   C1706074:Tables [Intellectual Product]
   737 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "figures."
Processing 00000000.tx.45: Measurements of insulin release. 

Phrase: "Measurements of insulin release."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0202098:Insulin measurement [Laboratory Procedure]
   770   C0242485:measurements [Functional Concept]
Processing 00000000.tx.46: Individual islets were placed in a 10-l chamber and perifused at 37C in the presence or absence of 3 mmol/l glucose. 

Phrase: "Individual islets"

Phrase: "were"

Phrase: "placed in a 10-l chamber"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0935616:Chamber [Body Part, Organ, or Organ Component]
   719   C0442504:Place [Spatial Concept]
   719   C1704765:Place [Functional Concept]
   719   C1882509:Place [Activity]
   719   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "perifused at 37C"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 3 mmol/l glucose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.47: The flow rate was kept constant throughout each experiment with the aid of a peristaltic pump placed before the islet. 

Phrase: "The flow rate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2826285:Flow Rate [Quantitative Concept]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "kept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333118:Keep [Functional Concept]

Phrase: "constant throughout each experiment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1547014:*Constant [Quantitative Concept]
   770   C1948059:Constant [Qualitative Concept]

Phrase: "with the aid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018896:Aid [Social Behavior]
  1000   C0449435:Aid [Manufactured Object]
  1000   C3540469:AID [Gene or Genome]

Phrase: "of a peristaltic pump"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0182537:Pump [Medical Device]
   861   C1706421:Pump [Manufactured Object]
   789   C0031133:Peristalses [Organ or Tissue Function]

Phrase: "placed before the islet."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.48: Variation in the flow rate of 150200 l/min was allowed between experiments. 

Phrase: "Variation in the flow rate of 150200 l/min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205419:Variation [Qualitative Concept]

Phrase: "was"

Phrase: "allowed between experiments."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0681814:Experiments [Research Activity]
   790   C0683607:allowed [Social Behavior]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.49: These variations did not affect the insulin release pattern. 

Phrase: "These variations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variations [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the insulin release pattern."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Pattern [Spatial Concept]
Processing 00000000.tx.50: After 60 min, collection of perifusate in 20-s fractions began. 

Phrase: "After 60 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "collection of perifusate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1516698:Collection [Functional Concept]
   790   C1704814:Collection [Idea or Concept]
   718 E C1516695:Collected [Idea or Concept]

Phrase: "in 20-s fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "began."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]
Processing 00000000.tx.51: The samples were immediately cooled on ice. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "cooled on ice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   756   C1548792:Cool [Qualitative Concept]
Processing 00000000.tx.52: For islets perifused in the presence of 3 mmol/l glucose, the sugar concentration was raised to 11 mmol/l, and subsequently 1 mmol/l tolbutamide was added to the perifusion medium. 

Phrase: "For islets"

Phrase: "perifused in the presence of 3 mmol/l glucose,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1532563:mmol/L [Quantitative Concept]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0439190:MMOLE [Quantitative Concept]

Phrase: "the sugar concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "raised to 11 mmol/l,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1532563:mmol/L [Quantitative Concept]
   760   C0439190:MMOLE [Quantitative Concept]
   760   C0442818:Raised [Quantitative Concept]

Phrase: "and"

Phrase: "subsequently 1 mmol/l tolbutamide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   748 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "added to the perifusion medium."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1524062:Added [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726 E C1883712:Add [Functional Concept]
Processing 00000000.tx.53: For islets perifused in the absence of glucose, 11 mmol/l KIC was added to the perifusion medium. 

Phrase: "For islets"

Phrase: "perifused in the absence of glucose,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "11 mmol/l KIC"

Phrase: "was"

Phrase: "added to the perifusion medium."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1524062:Added [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726 E C1883712:Add [Functional Concept]
Processing 00000000.tx.54: The perifusates were analyzed for insulin by a competitive enzyme-linked immunosorbent assay with the insulin-capturing antibody immobilized directly in the solid phase (19). 

Phrase: "The perifusates"

Phrase: "were"

Phrase: "analyzed for insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0936012:Analyzed [Research Activity]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "by a competitive enzyme-linked immunosorbent assay"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   937   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   875   C2717977:Enzyme Assay [Laboratory Procedure]
   804   C0005507:Assay [Laboratory Procedure]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]
   771   C1517892:Link [Intellectual Product]
   771   C1704666:Link [Intellectual Product]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "with the insulin-capturing antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0021644:Insulin antibody [Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "immobilized"

Phrase: "directly in the solid phase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205208:Solid [Qualitative Concept]
   760   C0205390:Phase [Temporal Concept]
   760   C0302909:Solid [Substance]
   760   C1378566:Solid [Biomedical or Dental Material]
   760   C1947931:Directly [Qualitative Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.55: The rate of insulin release was normalized to islet dry weight after freeze-drying and weighing using a quartz fiber balance. 

Phrase: "The rate of insulin release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "normalized to islet dry weight"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C2709005:Dry weight [Organism Attribute]
   760   C0005910:weight [Organism Attribute]
   760   C0011682:Dry [Natural Phenomenon or Process]
   760   C0043100:Weight [Quantitative Concept]
   760   C0205222:Dry [Qualitative Concept]
   760   C1305866:weight [Diagnostic Procedure]
   760   C1512080:Dry [Qualitative Concept]
   760   C1705104:Weight [Idea or Concept]
   760   C1882115:Normalized [Research Activity]

Phrase: "after"

Phrase: "freeze-drying"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0016698:Freeze Drying [Laboratory Procedure]
   861   C0011682:drying [Natural Phenomenon or Process]
   861   C0016701:Freeze [Natural Phenomenon or Process]
   827 E C0205222:Dry [Qualitative Concept]
   827 E C1512080:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "weighing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1305866:Weighing [Diagnostic Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a quartz fiber balance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0014653:Balance [Organism Function]
   827   C0205415:Balance [Functional Concept]
   827   C0560184:Balance [Finding]
Processing 00000000.tx.56: The islets weighed 12 g. 

Phrase: "The islets"

Phrase: "weighed"

Phrase: "12 g."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.57: Measurements of oxygen tension. 

Phrase: "Measurements of oxygen tension."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0523806:measurements oxygen [Laboratory Procedure]
   770   C0242485:measurements [Functional Concept]
Processing 00000000.tx.58: Individual islets were attached to a poly-L-lysinecoated coverslip, used as a bottom in an open Sykes-Moore perifusion chamber (20). 

Phrase: "Individual islets"

Phrase: "were"

Phrase: "attached to a poly-L-lysinecoated coverslip,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   774   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   748   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0231441:Attached [Finding]
   748   C0747726:POLY [Conceptual Entity]
   714 E C1314972:ATTACH [Intellectual Product]

Phrase: "used as a bottom"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1273517:used [Finding]
   770   C1511276:Bottom [Spatial Concept]
   770   C1552825:bottom [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "in an open Sykes-Moore perifusion chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.59: The chamber was thermostated to 37C. 

Phrase: "The chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "thermostated to 37C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1710386:Thermostat [Manufactured Object]
Processing 00000000.tx.60: The islets were perifused at a rate of 150160 l/min. 

Phrase: "The islets"

Phrase: "were"

Phrase: "perifused at a rate of 150160 l/min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0702093:/min [Temporal Concept]
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.61: Oxygen tension in the isolated islets was measured by a modified Clark microelectrode (21,22). 

Phrase: "Oxygen tension in the isolated islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0202155:oxygen tension [Laboratory Procedure]
   790   C1536627:oxygen tension [Physiologic Function]
   753   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0233494:Tension [Mental or Behavioral Dysfunction]

Phrase: "was"

Phrase: "measured by a modified Clark microelectrode"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   783   C0205349:Modified By [Qualitative Concept]
   753   C0025973:Microelectrode [Medical Device]
   753   C0392747:Modified [Functional Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "(21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.62: The tip of the microelectrode was positioned into the islets with the aid of a micromanipulator. 

Phrase: "The tip of the microelectrode"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1710425:Tip [Medical Device]
   760   C3282898:Tip [Qualitative Concept]

Phrase: "was"

Phrase: "positioned into the islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0733755:Position [Spatial Concept]

Phrase: "with the aid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018896:Aid [Social Behavior]
  1000   C0449435:Aid [Manufactured Object]
  1000   C3540469:AID [Gene or Genome]

Phrase: "of a micromanipulator."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0181835:micromanipulator [Medical Device]
Processing 00000000.tx.63: A stereomicroscope was used to control the penetration depth of the electrode, which was 2550 m. 

Phrase: "A stereomicroscope"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the penetration depth of the electrode,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0491577:ELECTRODE, DEPTH [Medical Device]
   753   C0205125:Depth [Spatial Concept]

Phrase: "which"

Phrase: "was"

Phrase: "2550 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.64: The electrode was polarized at -0.8 V, which gave a linear response between the oxygen tension and the electrode current. 

Phrase: "The electrode"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013812:electrode [Medical Device]
  1000   C1705652:Electrode [Medical Device]

Phrase: "was"

Phrase: "polarized"

Phrase: "at -0.8 V,"

Phrase: "which"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a linear response between the oxygen tension"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "the electrode current."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0521116:Current [Temporal Concept]
   861   C1705970:Current [Natural Phenomenon or Process]
Processing 00000000.tx.65: The electrical current was measured by a picoamperemeter (University of Aarhus, Aarhus, Denmark). 

Phrase: "The electrical current"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1705970:Electrical Current [Natural Phenomenon or Process]
           Current
   861   C0521116:Current [Temporal Concept]

Phrase: "was"

Phrase: "measured by a picoamperemeter"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "(University of Aarhus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Aarhus,"

Phrase: "Denmark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011318:Denmark [Geographic Area]

Phrase: ")."
Processing 00000000.tx.66: After insertion of the electrode, the islets were allowed to equilibrate for 50 min in the presence or absence of 3 mmol/l glucose before sampling began. 

Phrase: "After insertion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]

Phrase: "of the electrode,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013812:electrode [Medical Device]
  1000   C1705652:Electrode [Medical Device]

Phrase: "the islets"

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "equilibrate for 50 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 3 mmol/l glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "before sampling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441621:Sampling [Diagnostic Procedure]
  1000   C0870078:Sampling [Idea or Concept]

Phrase: "began."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]
Processing 00000000.tx.67: The sampling rate of the A/D converter was four data points per second. 

Phrase: "The sampling rate of the A/D converter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "four data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "points per second."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0205436:Second [Quantitative Concept]
   790   C0457385:Second [Temporal Concept]
   790   C0565930:/second [Quantitative Concept]
   790   C1552961:Point [Quantitative Concept]
   790   C1561503:second [Idea or Concept]
   790   C1705190:Second [Qualitative Concept]
   790   C2347617:point [Quantitative Concept]
   718 E C0027627:secondary [Neoplastic Process]
   718 E C0175668:Secondary [Temporal Concept]
Processing 00000000.tx.68: Averages of data points acquired during 20 s were calculated and used for further data presentation. 

Phrase: "Averages of data points"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1510992:Average [Quantitative Concept]
   737   C2825518:AVERAGE [Quantitative Concept]

Phrase: "acquired during 20 s"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439661:Acquired [Temporal Concept]
   770   C3245488:acquired [Intellectual Product]
   737 E C1706701:Acquire [Activity]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "and"

Phrase: "used for further data presentation."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0449450:Presentation [Idea or Concept]
   760   C1273517:used [Finding]
   760   C1511726:Data [Idea or Concept]
   760   C1517331:Further [Spatial Concept]
   760   C3245479:data [Medical Device]
   726 E C0042153:use [Functional Concept]
   726 E C0205108:far [Spatial Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.69: For islets perifused in the presence of 3 mmol/l glucose, the sugar concentration was raised to 11 mmol/l. 

Phrase: "For islets"

Phrase: "perifused in the presence of 3 mmol/l glucose,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1532563:mmol/L [Quantitative Concept]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0439190:MMOLE [Quantitative Concept]

Phrase: "the sugar concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "raised to 11 mmol/l."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1532563:mmol/L [Quantitative Concept]
   760   C0439190:MMOLE [Quantitative Concept]
   760   C0442818:Raised [Quantitative Concept]
Processing 00000000.tx.70: For islets perifused in the absence of glucose, 11 mmol/l KIC was added to the perifusion medium. 

Phrase: "For islets"

Phrase: "perifused in the absence of glucose,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "11 mmol/l KIC"

Phrase: "was"

Phrase: "added to the perifusion medium."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1524062:Added [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726 E C1883712:Add [Functional Concept]
Processing 00000000.tx.71: Oxygen tensions at 11 mmol/l glucose and 11 mmol/l KIC were obtained 15 min after raising the glucose concentration or adding KIC, when oxygen tension had stabilized. 

Phrase: "Oxygen tensions at 11 mmol/l glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0233494:tensions [Mental or Behavioral Dysfunction]
   745   C0202155:oxygen tension [Laboratory Procedure]
   745   C1536627:oxygen tension [Physiologic Function]

Phrase: "and"

Phrase: "11 mmol/l KIC"

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "15 min after raising"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "the glucose concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427743:Glucose concentration [Laboratory Procedure]
  1000   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "or"

Phrase: "adding KIC,"

Phrase: "when"

Phrase: "oxygen tension"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0202155:oxygen tension [Laboratory Procedure]
  1000   C1536627:oxygen tension [Physiologic Function]
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0233494:Tension [Mental or Behavioral Dysfunction]

Phrase: "had"

Phrase: "stabilized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:Stabilized [Qualitative Concept]
Processing 00000000.tx.72: The electrodes were calibrated in water saturated with Na2S2O5 or air at 37C before and after the experiments. 

Phrase: "The electrodes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013812:Electrodes [Medical Device]
   966 E C1705652:Electrode [Medical Device]

Phrase: "were"

Phrase: "calibrated in water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1550678:Water [Inorganic Chemical]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "saturated with Na2S2O5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0522534:Saturated [Phenomenon or Process]
   790   C1705188:SATURATED [Quantitative Concept]

Phrase: "or"

Phrase: "air at 37C"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0001861:Air [Substance]
   790   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   706 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "before"

Phrase: "and after the experiments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1515981:And [Idea or Concept]
   737 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.73: The drift of the microelectrodes was <0.5% / h. 

Phrase: "The drift of the microelectrodes"

Phrase: "was <"

Phrase: "0.5% / h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
   734   C0444499:0/5 [Quantitative Concept]
Processing 00000000.tx.74: Data analysis. 

Phrase: "Data analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1524024:analysis [Functional Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.75: The data points for insulin secretion in the figures represent three-point moving averages. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "points for insulin secretion"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1552961:Point [Quantitative Concept]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C2347617:point [Quantitative Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in the figures"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "three-point moving averages."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1510992:Average [Quantitative Concept]
   779   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.76: To analyze the oscillations of insulin release, we collected perifusates from islets exposed to 11 mmol/l glucose and tolbutamide to ensure sufficient amounts of insulin. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "the oscillations of insulin release,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "we"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "perifusates from islets"

Phrase: "exposed to 11 mmol/l glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]

Phrase: "and"

Phrase: "tolbutamide to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   805 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "sufficient amounts of insulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]
Processing 00000000.tx.77: Frequency determination of oscillations in insulin release was performed by Fourier transformation on both original and autocorrelated data using Igor software (Wave Metrics, Lake Oswego, OR). 

Phrase: "Frequency determination of oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1148554:determination [Laboratory Procedure]

Phrase: "in insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "performed by Fourier transformation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1550369:Performed By [Qualitative Concept]
   770   C0040682:Transformation [Cell Function]
   770   C0884358:Performed [Functional Concept]
   770   C1510411:Transformation [Pathologic Function]
   770   C1705163:Transformation [Research Activity]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "on both original"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205313:Original [Idea or Concept]
  1000   C2347409:Original [Occupational Activity]

Phrase: "and"

Phrase: "autocorrelated data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Igor software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Wave Metrics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0699680:metrics [Organic Chemical,Pharmacologic Substance]

Phrase: "Lake Oswego,"

Phrase: "OR"

Phrase: ")."
Processing 00000000.tx.78: Results are expressed as means  SE. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as means  SE."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.79: Differences in mean insulin secretory rates and oxygen tension between groups were evaluated with one-way analysis of variance with Fishers post hoc test. 

Phrase: "Differences in mean insulin secretory rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "oxygen tension between groups"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0202155:oxygen tension [Laboratory Procedure]
   833   C1536627:oxygen tension [Physiologic Function]
   770   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0233494:Tension [Mental or Behavioral Dysfunction]

Phrase: "were"

Phrase: "evaluated with one-way analysis of variance"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   897   C1709320:One-way Analysis of Variance [Quantitative Concept]
   814   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0205447:One [Quantitative Concept]
   748   C0220825:Evaluated [Functional Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1711260:Variance [Qualitative Concept]
   748   C2348152:Variance [Quantitative Concept]

Phrase: "with Fishers post hoc test."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   886   C1708064:Fisher's Test [Intellectual Product]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
Processing 00000000.tx.80: Differences within groups were evaluated with Students t test for paired data.  

Phrase: "Differences within groups"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "evaluated with Students t test"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:Students [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0220825:Evaluated [Functional Concept]
   760   C0392366:test [Intellectual Product]
   726 E C1551041:student [Idea or Concept]
   726 E C1552573:student [Intellectual Product]

Phrase: "for paired data."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2825412:Paired Data [Idea or Concept]
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.81: RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Insulin release in response to glucose and tolbutamide. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Insulin release in response"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1963578:Release [Therapeutic or Preventive Procedure]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "tolbutamide."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   944 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.82: Insulin release from individual islets was measured at 3 and 11 mmol/l glucose (Table 1, Fig. 1). 

Phrase: "Insulin release from individual islets"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1963578:Release [Therapeutic or Preventive Procedure]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "was"

Phrase: "measured at 3"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "11 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(Table 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.83: At basal glucose, insulin release was 5.3  1.5 and 4.2  1.1 pmol  g-1  s-1 from islets isolated from congenic strains Niddm1f and Niddm1i, respectively. 

Phrase: "At basal glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "5.3  1.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0450380:5/5 [Quantitative Concept]
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "4.2  1.1 pmol  g-1  s-1"

Phrase: "from islets"

Phrase: "isolated from congenic strains Niddm1f"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C1516786:Congenic Strain [Animal]
   760   C0080194:Strains [Injury or Poisoning]
   760   C0205409:Isolated [Functional Concept]
   760   C0456178:strains [Intellectual Product]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1518614:Strain [Organism]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
   726 E C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "Niddm1i,"

Phrase: "respectively."
Processing 00000000.tx.84: Similar results were obtained from islets isolated from control F344 and diabetic GK rats. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained from islets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "isolated from control F344"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0034703:F344 [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetic GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.85: When the glucose concentration was increased to 11 mmol/l, the rate of insulin release doubled in islets from Niddm1f and normoglycemic F344 rats. 

Phrase: "When"

Phrase: "the glucose concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427743:Glucose concentration [Laboratory Procedure]
  1000   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "increased to 11 mmol/l,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1532563:mmol/L [Quantitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0439190:MMOLE [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "the rate of insulin release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "doubled in islets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205173:doubled [Functional Concept]
   756 E C1705764:Double [Activity]
   756 E C1705765:Double [Qualitative Concept]

Phrase: "from Niddm1f"

Phrase: "and"

Phrase: "normoglycemic F344 rats."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034703:Rats, F344 [Mammal]
           F344
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.86: In contrast, no change in the insulin secretory rate was observed from Niddm1i and GK islets when the glucose concentration was raised to 11 mmol/l. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "no change in the insulin secretory rate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0442739:No change [Finding]
   778   C1548568:No change [Intellectual Product]
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "observed from Niddm1i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "GK islets"

Phrase: "when"

Phrase: "the glucose concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427743:Glucose concentration [Laboratory Procedure]
  1000   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "raised to 11 mmol/l."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1532563:mmol/L [Quantitative Concept]
   760   C0439190:MMOLE [Quantitative Concept]
   760   C0442818:Raised [Quantitative Concept]
Processing 00000000.tx.87: View this table: [in this window] [in a new window]  TABLE 1 Insulin release from F344, congenic, and GK rat islets in response to glucose and tolbutamide  View larger version (26K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Insulin release from F344,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "congenic,"

Phrase: "and"

Phrase: "GK rat islets in response"

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "tolbutamide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   944 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.88: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.89: Insulin release from individual islets isolated from control F344 (A), Niddm1f (B), Niddm1i (C), and GK (D) rats perifused in the presence of 3 and 11 mmol/l glucose and tolbutamide. 

Phrase: "Insulin release from individual islets"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1963578:Release [Therapeutic or Preventive Procedure]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "isolated from control F344"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0034703:F344 [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "Niddm1f"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Niddm1i"

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "GK ("

Phrase: "D)"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "perifused in the presence of 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "11 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "tolbutamide."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   944 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.90: Representative experiments of 9 (A), 10 (B), 9 (C), and 9 (D).  

Phrase: "Representative experiments of 9"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "10"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "9"

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "9"

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.91: The effect of the nonmetabolizable secretagogue tolbutamide on insulin release from islets was evaluated in the presence of 11 mmol/l glucose (Table 1, Fig. 1). 

Phrase: "The effect of the nonmetabolizable secretagogue tolbutamide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "from islets"

Phrase: "was"

Phrase: "evaluated in the presence of 11 mmol/l glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1532563:mmol/L [Quantitative Concept]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0220825:Evaluated [Functional Concept]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0439190:MMOLE [Quantitative Concept]

Phrase: "(Table 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.92: The addition of 1 mmol/l of the sulfonylurea to the perifusion medium increased insulin release threefold in islets from all four strains. 

Phrase: "The addition of 1 mmol/l of the sulfonylurea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1883712:Addition [Functional Concept]

Phrase: "to the perifusion medium increased insulin release"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   840   C0020459:increased insulin [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0030685:Release [Health Care Activity]
   804   C0391871:Release [Functional Concept]
   804   C0439180:% release [Quantitative Concept]
   804   C0680255:release [Health Care Activity]
   804   C1283071:Release [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1963578:Release [Therapeutic or Preventive Procedure]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "threefold in islets"

Phrase: "from all four strains."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]
Processing 00000000.tx.93: However, the secretory rates in the presence of 11 mmol/l glucose and tolbutamide differed substantially, with a significantly (P < 0.01) lower absolute rate in Niddm1i islets as compared with F344 islets. 

Phrase: "However,"

Phrase: "the secretory rates in the presence of 11 mmol/l glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0036542:Secretory Rates [Quantitative Concept]
   738   C1327616:Secretory [Cell Function]
   704   C0871208:Rate [Activity]
   704   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "tolbutamide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   944 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]

Phrase: "differed"

Phrase: "substantially,"

Phrase: "with a significantly"

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "absolute rate in Niddm1i islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "as"

Phrase: "compared with F344 islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034703:F344 [Mammal]
   770   C1707455:Compared [Activity]
Processing 00000000.tx.94: Islets from all four strains released insulin in pulses, with frequencies ranging from 0.37 to 0.39 min-1 (Table 1). 

Phrase: "Islets from all four"

Phrase: "strains"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]
   944 E C0180860:Filter [Manufactured Object]
   944 E C0581406:Filter [Medical Device]
   944 E C1522664:Filter [Intellectual Product]
   944 E C1704449:Filter [Conceptual Entity]
   944 E C1704684:Filter [Medical Device]
   944 E C1875155:FILTER [Medical Device]
   916 E C0442694:Straining [Physiologic Function]

Phrase: "released insulin in pulses,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "with frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0439603:Frequencies [Temporal Concept]
   966 E C0376249:frequency [Quantitative Concept]
   966 E C0871396:Frequency [Quantitative Concept]
   966 E C1561548:Frequency [Qualitative Concept]
   966 E C1705502:Frequency [Quantitative Concept]
   916 E C0332183:Frequent [Temporal Concept]

Phrase: "ranging from 0.37"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "to 0.39 min-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1301862:Min 1 [Temporal Concept]
   812   C0702093:/min [Temporal Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.95: Insulin release in response to KIC. 

Phrase: "Insulin release in response to KIC."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.96: The effect of KIC on insulin release from individual islets was assessed in the absence of glucose (Table 2, Fig. 2). 

Phrase: "The effect of KIC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "from individual islets"

Phrase: "was"

Phrase: "assessed in the absence of glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C1516048:Assessed [Activity]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "(Table 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.97: In the absence of glucose, insulin release was similar to that observed at 3 mmol/l glucose. 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "observed at 3 mmol/l glucose."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
   753   C1441672:Observed [Functional Concept]
Processing 00000000.tx.98: Introduction of 11 mmol/l KIC to the perifusion medium caused a prompt rise in insulin release in Niddm1f, Niddm1i, and control F344 islets. 

Phrase: "Introduction of 11 mmol/l KIC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1293116:Introduction [Health Care Activity]
   753   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "to the perifusion medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a prompt rise in insulin release"

Phrase: "in Niddm1f,"

Phrase: "Niddm1i,"

Phrase: "and"

Phrase: "control F344 islets."
Processing 00000000.tx.99: In these islets, insulin release increased approximately eightfold during the first 5 min upon exposure to KIC. 

Phrase: "In these islets,"

Phrase: "insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "approximately eightfold during the first 5 min"

Phrase: "upon exposure to KIC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0332157:Exposure to [Clinical Attribute]
Processing 00000000.tx.100: In contrast, insulin release from GK islets was not affected by KIC. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "insulin release from GK islets"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1963578:Release [Therapeutic or Preventive Procedure]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by KIC."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
Processing 00000000.tx.101: View this table: [in this window] [in a new window]  TABLE 2 Insulin release from F344, congenic, and GK rat islets in response to KIC  View larger version (18K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2 Insulin release from F344,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "congenic,"

Phrase: "and"

Phrase: "GK rat islets in response to KIC  View larger version"

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.102: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.103: Insulin release from individual islets isolated from control F344 (A), Niddm1f (B), Niddm1i (C), and GK (D) rats perifused in the absence or presence of 11 mmol/l KIC. 

Phrase: "Insulin release from individual islets"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1963578:Release [Therapeutic or Preventive Procedure]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "isolated from control F344"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0034703:F344 [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "Niddm1f"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Niddm1i"

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "GK ("

Phrase: "D)"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "perifused in the absence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "presence of 11 mmol/l KIC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.104: Representative experiments of 11 (A), 8 (B), 7 (C), and 7 (D).  

Phrase: "Representative experiments of 11"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "8"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "7"

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "7"

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.105: Oxygen tension in response to glucose. 

Phrase: "Oxygen tension in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0202155:oxygen tension [Laboratory Procedure]
   833   C1536627:oxygen tension [Physiologic Function]
   770   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0233494:Tension [Mental or Behavioral Dysfunction]

Phrase: "to glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.106: Oxygen tension was measured from isolated islets in the presence of 3 and 11 mmol/l glucose (Table 3, Fig. 3). 

Phrase: "Oxygen tension"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0202155:oxygen tension [Laboratory Procedure]
  1000   C1536627:oxygen tension [Physiologic Function]
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0233494:Tension [Mental or Behavioral Dysfunction]

Phrase: "was"

Phrase: "measured from isolated islets"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0449770:Measured from [Quantitative Concept]
   770   C0205409:Isolated [Functional Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "11 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(Table 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.107: At low glucose, pO2 in islets from congenic Niddm1f and Niddm1i rats was 121.8  3.9 and 125.1  3.0 mmHg, respectively. 

Phrase: "At low glucose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860801:low glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "pO2 in islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0202155:pO2 [Laboratory Procedure]
   790   C1283004:PO2 [Laboratory Procedure]

Phrase: "from congenic Niddm1f"

Phrase: "and"

Phrase: "Niddm1i rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "was"

Phrase: "121.8  3.9"

Phrase: "and"

Phrase: "125.1  3.0 mmHg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439475:mmHg [Quantitative Concept]

Phrase: "respectively."
Processing 00000000.tx.108: Similar results were obtained for control and GK islets. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained for control"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1301820:Obtained [Functional Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "GK islets."
Processing 00000000.tx.109: Raising the glucose concentration to 11 mmol/l caused a significant decrease of pO2 by 6% in islets from Niddm1f, Niddm1i, F344, and GK rats. 

Phrase: "Raising"

Phrase: "the glucose concentration to 11 mmol/l"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0427743:Glucose concentration [Laboratory Procedure]
   778   C1287281:Glucose concentration [Laboratory or Test Result]
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a significant decrease of pO2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "by 6%"

Phrase: "in islets"

Phrase: "from Niddm1f,"

Phrase: "Niddm1i,"

Phrase: "F344,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]

Phrase: "and"

Phrase: "GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.110: View this table: [in this window] [in a new window]  TABLE 3 Oxygen tension in F344, congenic, and GK rat islets in response to glucose  View larger version (14K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 3 Oxygen tension in F344,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0202155:oxygen tension [Laboratory Procedure]
   790   C1536627:oxygen tension [Physiologic Function]
   753   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0233494:Tension [Mental or Behavioral Dysfunction]

Phrase: "congenic,"

Phrase: "and"

Phrase: "GK rat islets in response"

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.111: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.112: Oxygen tension measurements from individual islets isolated from control F344 (A), Niddm1f (B), Niddm1i (C), and GK (D) rats perifused in the presence of 3 and 11 mmol/l glucose. 

Phrase: "Oxygen tension measurements from individual islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0523806:measurements oxygen [Laboratory Procedure]
   753   C0242485:measurements [Functional Concept]

Phrase: "isolated from control F344"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0034703:F344 [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "Niddm1f"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Niddm1i"

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "GK ("

Phrase: "D)"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "perifused in the presence of 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "11 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.113: Representative experiments of 10 (A), 6 (B), 9 (C), and 6 (D).  

Phrase: "Representative experiments of 10"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "6"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "9"

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "6"

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.114: Oxygen tension in response to KIC. 

Phrase: "Oxygen tension in response to KIC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0202155:oxygen tension [Laboratory Procedure]
   790   C1536627:oxygen tension [Physiologic Function]
   753   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0233494:Tension [Mental or Behavioral Dysfunction]
Processing 00000000.tx.115: The effect of KIC on pO2 in islets from the four rat strains was determined in the absence of glucose (Table 4, Fig. 4). 

Phrase: "The effect of KIC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on pO2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0202155:pO2 [Laboratory Procedure]
  1000   C1283004:PO2 [Laboratory Procedure]

Phrase: "in islets"

Phrase: "from the four rat strains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C1514734:Rat Strains [Mammal]
   827   C0080194:Strains [Injury or Poisoning]
   827   C0456178:strains [Intellectual Product]
   793 E C1518614:Strain [Organism]
   793 E C2987481:Strain [Mental Process]

Phrase: "was"

Phrase: "determined in the absence of glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "(Table 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.116: In the absence of glucose, pO2 was similar to that recorded at 3 mmol/l glucose. 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "pO2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0202155:pO2 [Laboratory Procedure]
  1000   C1283004:PO2 [Laboratory Procedure]

Phrase: "was"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "recorded at 3 mmol/l glucose."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
   719   C0034869:Record [Intellectual Product]
Processing 00000000.tx.117: In islets from Niddm1f and Niddm1i rats, 11 mmol/l KIC decreased pO2 by 15%. 

Phrase: "In islets"

Phrase: "from Niddm1f"

Phrase: "and"

Phrase: "Niddm1i rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "11 mmol/l KIC decreased pO2 by 15%."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0202155:pO2 [Laboratory Procedure]
   744   C1283004:PO2 [Laboratory Procedure]
Processing 00000000.tx.118: Whereas a similar reduction in pO2 was observed in islets from F344 rats, pO2 was not significantly decreased in islets from GK rats. 

Phrase: "Whereas"

Phrase: "a similar reduction in pO2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "observed in islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "from F344 rats,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034703:Rats, F344 [Mammal]
           F344
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "pO2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0202155:pO2 [Laboratory Procedure]
  1000   C1283004:PO2 [Laboratory Procedure]

Phrase: "was"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "decreased in islets"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "from GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.119: View this table: [in this window] [in a new window]  TABLE 4 Oxygen tension in F344, congenic, and GK rat islets in response to KIC  View larger version (14K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 4 Oxygen tension in F344,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0202155:oxygen tension [Laboratory Procedure]
   790   C1536627:oxygen tension [Physiologic Function]
   753   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0233494:Tension [Mental or Behavioral Dysfunction]

Phrase: "congenic,"

Phrase: "and"

Phrase: "GK rat islets in response to KIC  View larger version"

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.120: 4. 

Phrase: "4."
Processing 00000000.tx.121: Oxygen tension measurements from individual islets isolated from control F344 (A), Niddm1f (B), Niddm1i (C), and GK (D) rats perifused in the absence or presence of 11 mmol/l KIC. 

Phrase: "Oxygen tension measurements from individual islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0523806:measurements oxygen [Laboratory Procedure]
   753   C0242485:measurements [Functional Concept]

Phrase: "isolated from control F344"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0034703:F344 [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "Niddm1f"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Niddm1i"

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "GK ("

Phrase: "D)"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "perifused in the absence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "presence of 11 mmol/l KIC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.122: Representative experiments of seven (A), four (B), seven (C), and five (D).   

Phrase: "Representative experiments of seven"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "seven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205453:Seven [Quantitative Concept]

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "five"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205451:Five [Quantitative Concept]

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.123: DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  The GK rat was established as a diabetes model by selection for offspring with hyperglycemia in successive generations, followed by sisterbrother inbreeding to obtain a homozygous strain (23). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The GK rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]

Phrase: "was"

Phrase: "established as a diabetes model"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0443211:Established [Qualitative Concept]
   760   C1272684:Established [Qualitative Concept]
   760   C3161035:Model [Intellectual Product]

Phrase: "by selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036576:selection [Genetic Function]

Phrase: "for offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680063:Offspring [Family Group]

Phrase: "with hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "in successive generations,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0079411:Generations [Temporal Concept]
   827 E C3146294:Generation [Activity]
   761 E C1414672:Genesis [Gene or Genome]
   761 E C2984892:Genesis [Gene or Genome]

Phrase: "followed by sisterbrother inbreeding to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0021144:Inbreeding [Organism Function]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "a homozygous strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0080194:Strain [Injury or Poisoning]
   861   C0456178:strain [Intellectual Product]
   861   C1518614:Strain [Organism]
   861   C2987481:Strain [Mental Process]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.124: During the selection process, alleles that contribute to the diabetes phenotype were fixed along several different pathways, e.g., deranged insulin secretion, decreased insulin action in target tissues, dysregulated suppression of hepatic glucose production, or feeding behavior. 

Phrase: "During the selection process,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: "that"

Phrase: "contribute to the diabetes phenotype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0031437:Phenotype [Organism Attribute]
   760   C1285572:Phenotype [Laboratory Procedure]
   760   C1880177:Contribute [Activity]

Phrase: "were"

Phrase: "fixed along several different pathways,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0231441:Fixed [Finding]
   760   C0443218:Fixed [Qualitative Concept]
   760   C1704259:Pathways [Molecular Function]
   760   C1705242:Different [Qualitative Concept]
   760   C1705987:Pathways [Conceptual Entity]
   760   C2827483:Fixed [Body Substance]

Phrase: "e.g."

Phrase: ","

Phrase: "deranged insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "decreased insulin action in target tissues,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0441472:Action [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C3266814:Action [Activity]

Phrase: "dysregulated suppression of hepatic glucose production,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0221103:Suppression [Pathologic Function]
   753   C0301625:Suppression [Organism Function]
   753   C0439181:% suppression [Quantitative Concept]
   753   C0728721:suppression [Mental Process]

Phrase: "or"

Phrase: "feeding behavior."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0015745:Feeding Behavior [Individual Behavior]
   861   C0004927:Behavior [Individual Behavior]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]
Processing 00000000.tx.125: Exploration of the major diabetes QTL (Niddm1) (6) has led to the identification of one series of congenic rat strains that characterizes a sublocus with an insulin-resistance type of diabetes, Niddm1b/Niddm1f/Niddm1e. 

Phrase: "Exploration of the major diabetes QTL (Niddm1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1280903:Exploration [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "(6"

Phrase: ")"

Phrase: "has"

Phrase: "led to the identification of one series of congenic rat"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   739   C0020792:Identification [Mental Process]
   739   C0034693:Rat, NOS [Mammal]
   739   C0034721:Rat [Mammal]
   739   C0205396:Identification [Qualitative Concept]
   739   C0205447:One [Quantitative Concept]
   739   C0205549:Series [Quantitative Concept]
   739   C1708698:LED [Manufactured Object]
   739   C2348044:Series [Intellectual Product]
   706 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   706 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   706 E C1522538:Lead [Functional Concept]
   706 E C2348269:Lead [Element, Ion, or Isotope]
   706 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "strains"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]
   944 E C0180860:Filter [Manufactured Object]
   944 E C0581406:Filter [Medical Device]
   944 E C1522664:Filter [Intellectual Product]
   944 E C1704449:Filter [Conceptual Entity]
   944 E C1704684:Filter [Medical Device]
   944 E C1875155:FILTER [Medical Device]
   916 E C0442694:Straining [Physiologic Function]

Phrase: "that"

Phrase: "characterizes"

Phrase: "a sublocus with an insulin-resistance type of diabetes,"

Phrase: "Niddm1b/Niddm1f/Niddm1e."
Processing 00000000.tx.126: The corresponding congenic strains displayed postprandial hyperglycemia, fasting hyperinsulinemia, increased body weight and fat, reduced lipogenesis in isolated epididymal fat cells, and blunted insulin-stimulated glucose uptake in skeletal muscle (17,18). 

Phrase: "The corresponding congenic strains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   884   C1516786:Congenic Strain [Animal]
   827   C0080194:Strains [Injury or Poisoning]
   827   C0456178:strains [Intellectual Product]
   793 E C1518614:Strain [Organism]
   793 E C2987481:Strain [Mental Process]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "postprandial hyperglycemia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1855520:Hyperglycemia, Postprandial [Finding]
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "hyperinsulinemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "increased body weight"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0043094:Increased body weight [Finding]
           Increased weight
   901   C0005910:Body Weight [Organism Attribute]
           weight
   901   C1305866:body weight [Diagnostic Procedure]
           weight
   827   C0043100:Weight [Quantitative Concept]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   827   C1705104:Weight [Idea or Concept]
   743 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "fat,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0424612:FAT [Organism Attribute]

Phrase: "reduced lipogenesis in isolated epididymal fat cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0596843:lipogenesis [Molecular Function]
   748   C1563744:Lipogenesis [Organism Function]

Phrase: "and"

Phrase: "blunted insulin-stimulated glucose uptake in skeletal muscle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1159527:glucose uptake [Cell Function]
   767   C1719133:Glucose/Insulin [Quantitative Concept]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0243144:Uptake [Physiologic Function]
   744   C0347980:% uptake [Quantitative Concept]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.127: The disease-causing gene(s) was mapped to a 1-cM region that co-localized with the gene for insulin degrading enzyme. 

Phrase: "The disease-causing gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   885   C1416989:MAL gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   717   C1314792:disease cause [Functional Concept]

Phrase: "("

Phrase: "s)"

Phrase: "was"

Phrase: "mapped to a 1-cM region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1424473:MAP-1 [Gene or Genome]
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   719   C0024779:Map [Manufactured Object]
   719   C1706473:Map [Conceptual Entity]

Phrase: "that"

Phrase: "co-localized with the gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017337:Gene [Gene or Genome]
   760   C0392752:Localized [Spatial Concept]

Phrase: "for insulin degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.128: This region is common to all three congenic rat strains. 

Phrase: "This region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "common to all three congenic rat strains."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205214:Common [Quantitative Concept]
   748   C1522138:Common [Functional Concept]
   748   C3245511:common [Intellectual Product]
Processing 00000000.tx.129: The GK-derived enzyme encoded two amino acid substitutions that reduced enzyme activity by 30%. 

Phrase: "The GK-derived enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "encoded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679058:encoded [Mental Process]
  1000   C2700640:Encoded [Activity]

Phrase: "two amino acid substitutions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   779   C1555721:Substitution [Idea or Concept]
   779   C1706204:Substitution [Activity]

Phrase: "that reduced enzyme activity by 30%."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0243102:enzyme activity [Molecular Function]
   783   C0086439:Reduced Activity [Sign or Symptom]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.130: In the present report, we characterized the insulin secretory phenotype of Niddm1f and Niddm1i rats. 

Phrase: "In the present report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "the insulin secretory phenotype of Niddm1f"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]

Phrase: "and"

Phrase: "Niddm1i rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.131: Congenic rats were therefore studied at the level of individual pancreatic islets by measuring insulin release and oxygen tension under various conditions. 

Phrase: "Congenic rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "therefore"

Phrase: "studied at the level of individual pancreatic islets"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   744   C0027361:Individual [Population Group]
   744   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   744   C0237401:Individual [Human]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]
   711   C0557651:Study [Manufactured Object]
   711   C2603343:Study [Research Activity]

Phrase: "by measuring insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "oxygen tension under various conditions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0202155:oxygen tension [Laboratory Procedure]
   806   C1536627:oxygen tension [Physiologic Function]
   760   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0233494:Tension [Mental or Behavioral Dysfunction]
Processing 00000000.tx.132: The results show that changes in insulin release and oxygen tension in response to glucose, tolbutamide, and KIC in islets from Niddm1f rats are comparable to those in islets isolated from normoglycemic F344 rats. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that changes in insulin release"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "oxygen tension in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0202155:oxygen tension [Laboratory Procedure]
   833   C1536627:oxygen tension [Physiologic Function]
   770   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0233494:Tension [Mental or Behavioral Dysfunction]

Phrase: "to glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "tolbutamide,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   944 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "KIC in islets"

Phrase: "from Niddm1f rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "are"

Phrase: "comparable to those in islets"

Phrase: "isolated from normoglycemic F344 rats."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0034703:Rats, F344 [Mammal]
           F344
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205409:Isolated [Functional Concept]
   760   C0580545:Normoglycaemic [Finding]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.133: The findings confirm that the diabetes phenotype of the Niddm1f sublocus is not associated with any major defects in insulin secretion. 

Phrase: "The findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the diabetes phenotype of the Niddm1f sublocus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031437:Phenotype [Organism Attribute]
   748   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with any major defects"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0205164:Major [Qualitative Concept]
   760   C0243067:defects [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1457869:Defect [Functional Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.134: The other sublocus of Niddm1, Niddm1i, encodes reduced lipogenesis in isolated fat cells and a recessive postprandial hyperglycemia associated with whole-body postprandial serum insulin deficiency (17). 

Phrase: "The"

Phrase: "other sublocus of Niddm1,"

Phrase: "Niddm1i,"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "reduced lipogenesis in isolated fat cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0596843:lipogenesis [Molecular Function]
   753   C1563744:Lipogenesis [Organism Function]

Phrase: "and"

Phrase: "a recessive postprandial hyperglycemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1855520:Hyperglycemia, Postprandial [Finding]
   827   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "associated with whole-body postprandial serum insulin deficiency"
Meta Candidates (Total=23; Excluded=2; Pruned=0; Remaining=21)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0428357:Serum insulin [Laboratory Procedure]
   770   C0444584:Whole body [Anatomical Structure]
   770   C1261415:serum insulin [Laboratory or Test Result]
   770   C1546549:Whole body [Intellectual Product]
   770   C1550677:Whole body [Body Substance]
   744   C0011155:Deficiency [Functional Concept]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0162429:Deficiency [Disease or Syndrome]
   744   C0229671:Serum [Body Substance]
   744   C0242821:body [Human]
   744   C0376674:Postprandial [Temporal Concept]
   744   C0444667:Whole [Quantitative Concept]
   744   C0460148:Body [Anatomical Structure]
   744   C1268086:Body [Anatomical Structure]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1623416:deficiency [Qualitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.135: Congenic Niddm1i rats contain a 22-cM GK-derived chromosome region that is not contained in Niddm1b (17). 

Phrase: "Congenic Niddm1i rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a 22-cM GK-derived chromosome region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C1953345:Chromosome region [Cell]
   799   C0017446:Region [Geographic Area]
   799   C0205147:Region [Spatial Concept]
   727 E C0205276:Regional [Spatial Concept]
   727 E C1947913:Regional [Spatial Concept]
   709   C0008665:22 chromosome [Cell Component]

Phrase: "that"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contained in Niddm1b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332256:contained [Functional Concept]
   790   C2700400:Contained [Activity]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.136: Our present results, which show that islets from Niddm1i congenic rats are unable to respond with increased insulin secretion rate to a rise in glucose concentration from 3 to 11 mmol/l, strongly support the notion that Niddm1i encodes a defect in insulin secretion. 

Phrase: "Our present results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "which"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that islets from Niddm1i congenic rats"

Phrase: "are"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "respond with increased insulin secretion rate"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C1372360:Increased Insulin Secretion [Organ or Tissue Function]
   790   C0020459:increased insulin [Disease or Syndrome]
   790   C1256369:insulin secretion [Cell Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "to a rise"

Phrase: "in glucose concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427743:Glucose concentration [Laboratory Procedure]
  1000   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "from 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "to 11 mmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1532563:mmol/L [Quantitative Concept]

Phrase: "strongly"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the notion"

Phrase: "that Niddm1i"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a defect in insulin secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.137: Indeed, in 50% of the Niddm1i islets, the increase in the glucose concentration caused a reduction of insulin release. 

Phrase: "Indeed,"

Phrase: "in 50%"

Phrase: "of the Niddm1i islets,"

Phrase: "the increase in the glucose concentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a reduction of insulin release."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.138: This phenomenon has been observed in isolated islets as well as in the perfused pancreas from the GK rat (24). 

Phrase: "This phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "has"

Phrase: "been"

Phrase: "observed in isolated islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205409:Isolated [Functional Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]

Phrase: "as well as in the perfused pancreas"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   748   C0205170:Well [Qualitative Concept]
   748   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   748   C3146287:Well [Manufactured Object]
   714   C1549542:Perfuse [Functional Concept]

Phrase: "from the GK rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.139: This paradoxical insulin response to glucose has been explained by an imbalance between the action of glucose to increase the cytoplasmic Ca2+ concentration ([Ca2+]i) by depolarization and influx of the ion and to decrease [Ca2+]i by promoting intracellular sequestration and outward transport of the ion (25). 

Phrase: "This paradoxical insulin response to glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "has"

Phrase: "been"

Phrase: "explained by an imbalance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1397014:Imbalance [Sign or Symptom]

Phrase: "between the action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]

Phrase: "of glucose to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the cytoplasmic Ca2+ concentration ([Ca2+]i) by depolarization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "influx of the ion"

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i by promoting intracellular sequestration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "outward transport of the ion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0162585:Ion Transport [Cell Function]
   760   C0005528:Transport, NOS [Cell Function]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.140: If depolarization is impaired and influx of Ca2+ is reduced, then the lowering effect of glucose on [Ca2+]i will manifest itself in a reduction of insulin release. 

Phrase: "If"

Phrase: "depolarization"

Phrase: "is"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "and"

Phrase: "influx of Ca2+"

Phrase: "is"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: ","

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the lowering effect of glucose on [Ca2+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1158774:glucose effect [Genetic Function]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "will"

Phrase: "manifest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205319:Manifest [Functional Concept]

Phrase: "itself in a reduction of insulin release."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0030685:Release [Health Care Activity]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0391871:Release [Functional Concept]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.141: A transient lowering in plasma insulin is a common observation in patients with type 2 diabetes (26) and may be related to this phenomenon. 

Phrase: "A transient lowering in plasma insulin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0441994:lowering [Spatial Concept]
   753   C2003888:Lowering [Activity]
   719 E C1548802:Lower [Body Location or Region]

Phrase: "is"

Phrase: "a common observation in patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0700325:Patient observation [Health Care Activity]
           observation
   760   C0302523:Observation [Research Activity]
   760   C1964257:Observation [Diagnostic Procedure]

Phrase: "with type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(26"

Phrase: ")"

Phrase: "and"

Phrase: "may"

Phrase: "be"

Phrase: "related to this phenomenon."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C1882365:Phenomenon [Phenomenon or Process]
   737 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.142: The reason for the inability of glucose to stimulate insulin release adequately in the GK rat has been associated with defects in glucose metabolism in the pancreatic -cell (27,28). 

Phrase: "The reason for the inability of glucose to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392360:Reason [Idea or Concept]

Phrase: "stimulate"

Phrase: "insulin release adequately in the GK rat"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "associated with defects"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0243067:defects [Functional Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1457869:Defect [Functional Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   756 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "in the pancreatic -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.143: Deficient expression of pyruvate dehydrogenase (29), increased secretion of islet amyloid polypeptide (30), alterations in lysosomal enzymes (31), lowered cAMP levels (32), and low levels of mitochondrial glycerol phosphate dehydrogenase (33) all have been suggested in this context. 

Phrase: "Deficient expression of pyruvate dehydrogenase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "increased secretion of islet amyloid polypeptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "alterations in lysosomal enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0544948:Lysosome Alterations [Cell or Molecular Dysfunction]
   737   C1515926:Alteration [Idea or Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "lowered cAMP levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "low levels of mitochondrial glycerol phosphate dehydrogenase"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   774   C0428304:levels phosphate [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "(33"

Phrase: ")"

Phrase: "all"

Phrase: "have"

Phrase: "been"

Phrase: "suggested in this context."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449255:Context [Finding]
   770   C0542559:Context [Functional Concept]
   737   C1705535:Suggest [Idea or Concept]
Processing 00000000.tx.144: Glycerol phosphate dehydrogenase was mapped to rat chromosome 3 in the vicinity of a region linked to diabetes in GK rats (34). 

Phrase: "Glycerol phosphate dehydrogenase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0017875:Glycerolphosphate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0061557:Glycerol dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   827   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "mapped to rat chromosome 3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0008666:Chromosome 3 [Cell Component]
   781   C0814036:chromosome map [Intellectual Product]
   760   C0008633:Chromosome [Cell Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   726   C0024779:Map [Manufactured Object]
   726   C1706473:Map [Conceptual Entity]

Phrase: "in the vicinity"

Phrase: "of a region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "linked to diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   756   C1517892:Link [Intellectual Product]
   756   C1704666:Link [Intellectual Product]

Phrase: "in GK rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.145: However, overexpression of the enzyme in islets from GK rats was not able to alleviate the impaired glucose-induced insulin secretion (35). 

Phrase: "However,"

Phrase: "overexpression of the enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in islets"

Phrase: "from GK rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "was"

Phrase: "not able to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]
   827   C1518422:Not [Functional Concept]

Phrase: "alleviate"

Phrase: "the impaired glucose-induced insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C1719133:Glucose/Insulin [Quantitative Concept]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.146: Although glucose metabolism may be altered in the GK rat, normal Krebs cycle function has been observed in GK islets (36,37), which is compatible with our observation of a glucose-induced lowering of pO2 in GK and Niddm1i islets. 

Phrase: "Although"

Phrase: "glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "altered in the GK rat,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0392747:Altered [Functional Concept]

Phrase: "normal Krebs cycle function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "observed in GK islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1441672:Observed [Functional Concept]

Phrase: "(36,"

Phrase: "37"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "compatible with our observation of a glucose-induced lowering of pO2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0332290:compatible [Idea or Concept]
   738   C1524057:Compatible [Qualitative Concept]

Phrase: "in GK"

Phrase: "and"

Phrase: "Niddm1i islets."
Processing 00000000.tx.147: Such an increase in respiration, which is normally coupled to increased insulin release from the islet (22), in combination with the observed secretion impairment, could be explained by decreased coupling between oxidative metabolism and phosphorylation in the -cells in Niddm1i islets. 

Phrase: "Such"

Phrase: "an increase in respiration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "normally"

Phrase: "coupled to increased insulin release"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   806   C0020459:increased insulin [Disease or Syndrome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0030685:Release [Health Care Activity]
   760   C0205217:Increased [Quantitative Concept]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1948027:Coupled [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]
   726 E C0010222:couple [Family Group]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "from the islet"

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with the observed secretion impairment,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0684336:Impairment [Pathologic Function]

Phrase: "could"

Phrase: "be"

Phrase: "explained by decreased coupling"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C1948027:Coupling [Functional Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "between oxidative metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282636:oxidative metabolism [Cell Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "phosphorylation in the -cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "in Niddm1i islets."
Processing 00000000.tx.148: In support of this view, glucose-induced ATP production was lower in GK islets as compared with control islets (37). 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this view,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "glucose-induced ATP production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "lower in GK islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "as"

Phrase: "compared with control islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.149: A potential candidate for this action is uncoupling protein 2, the expression of which has been demonstrated to affect glucose-stimulated insulin release (38,39,40). 

Phrase: "A potential candidate for this action"

Phrase: "is"

Phrase: "uncoupling protein 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the expression of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "glucose-stimulated insulin release"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1963578:Release [Therapeutic or Preventive Procedure]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(38,"

Phrase: "39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.150: The secretory defect of the Niddm1i congene was further characterized by exposing the islets to tolbutamide. 

Phrase: "The secretory defect of the Niddm1i congene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1457869:Defect [Functional Concept]
   748   C1861101:DEFECT [Disease or Syndrome]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "characterized by exposing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332157:exposing [Clinical Attribute]
   790   C1880022:Characterized [Activity]

Phrase: "the islets to tolbutamide."
Processing 00000000.tx.151: This hypoglycemic sulfonylurea acts via closure of the ATP-sensitive K+-channels (41). 

Phrase: "This hypoglycemic sulfonylurea"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   861   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "acts via closure of the ATP-sensitive K+-channels"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0079613:ACT [Therapeutic or Preventive Procedure]
   742   C0185003:Closure [Therapeutic or Preventive Procedure]
   742   C0332324:Sensitive [Functional Concept]
   742   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C1521802:Closure [Research Activity]
   742   C1550474:sensitive [Idea or Concept]
   742   C1708601:K' [Quantitative Concept]
   708   C0439799:Channel [Spatial Concept]
   708   C1706095:Channel [Conceptual Entity]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.152: The stimulatory effect of tolbutamide on Niddm1i islets, although less pronounced than in control F344 islets, indicates that the channels are functional in Niddm1i islets as well as in GK islets, as shown previously (37,42). 

Phrase: "The stimulatory effect of tolbutamide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on Niddm1i islets,"

Phrase: "although"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "pronounced than"

Phrase: "in control F344 islets,"

Phrase: "indicates"

Phrase: "that"

Phrase: "the channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439799:Channel [Spatial Concept]
   966   C1706095:Channel [Conceptual Entity]

Phrase: "are"

Phrase: "functional in Niddm1i islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205245:Functional [Functional Concept]
   770   C0542341:Functional [Functional Concept]
   770   C2700217:Functional [Conceptual Entity]

Phrase: "as well as in GK islets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205170:Well [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "as"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously"

Phrase: "(37,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.153: When the mitochondrial substrate KIC (43) was added to the perifusion medium, insulin release was fully restored in Niddm1i islets. 

Phrase: "When"

Phrase: "the mitochondrial substrate KIC"

Phrase: "(43"

Phrase: ")"

Phrase: "was"

Phrase: "added to the perifusion medium,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1524062:Added [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726 E C1883712:Add [Functional Concept]

Phrase: "insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "fully"

Phrase: "restored in Niddm1i islets."
Processing 00000000.tx.154: KIC is the deamination product of L-leucine, a reaction catalyzed by branched-chain 2-ketoacid dehydrogenase (BCKDH). 

Phrase: "KIC"

Phrase: "is"

Phrase: "the deamination product of L-leucine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]

Phrase: "a reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "catalyzed by branched-chain 2-ketoacid dehydrogenase (BCKDH)."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   835   C0046494:Branched Chain Ketoacid Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0022618:Ketoacid [Organic Chemical]
   748   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0337112:Chain [Manufactured Object]
   748   C1253959:branched [Body Part, Organ, or Organ Component]
   748   C1524075:Chain [Idea or Concept]
   748   C2700384:Branched [Spatial Concept]
   714 E C1881507:Branch [Chemical Viewed Structurally]
   714 E C2700383:Branch [Plant]
   714 E C2826234:BRANCH [Intellectual Product]
Processing 00000000.tx.155: The ketoacid is then directly metabolized in the -cell mitochondria. 

Phrase: "The ketoacid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022618:Ketoacid [Organic Chemical]

Phrase: "is"

Phrase: "then directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883708:Then [Temporal Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "metabolized in the -cell mitochondria."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cell [Cell]
   760   C0026237:Mitochondria [Cell Component]
   760   C1269647:Cell [Cell]
   760   C1524026:Metabolized [Cell Function]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.156: This finding suggests that the decreased amount of insulin secreted in response to tolbutamide is probably due to insufficient ATP generation (37) for the energy-requiring process of recruiting granules for exocytosis (44,45), rather than decreased insulin content. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the decreased amount of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "secreted in response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0871261:Response [Organism Attribute]
   790   C1327616:Secreted [Cell Function]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to tolbutamide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   944 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "probably due to insufficient ATP generation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0079411:Generation [Temporal Concept]
   753   C0205412:Insufficient [Qualitative Concept]
   753   C0231180:Insufficient [Qualitative Concept]
   753   C0750492:Probably [Idea or Concept]
   753   C3146286:Due [Idea or Concept]
   753   C3146294:Generation [Activity]

Phrase: "(37"

Phrase: ")"

Phrase: "for the energy-requiring process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "of recruiting granules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   777 E C0205248:Granular [Qualitative Concept]

Phrase: "for exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]

Phrase: "(44,"

Phrase: "45"

Phrase: ")"

Phrase: ","

Phrase: "rather than"

Phrase: "decreased insulin content."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.157: In GK islets, the leucine deamination product produces a small (46) or, as observed in the present study, almost absent secretory response. 

Phrase: "In GK islets,"

Phrase: "the leucine deamination product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "produces"

Phrase: "a small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "(46"

Phrase: ")"

Phrase: "or"

Phrase: ","

Phrase: "as"

Phrase: "observed in the present study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1441672:Observed [Functional Concept]
   760   C2603343:Study [Research Activity]

Phrase: "almost absent secretory response."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
Processing 00000000.tx.158: This may be related to reduced generation of acetyl-CoA from KIC as a result of defective decarboxylation of this ketoacid by the mitochondrial BCKDH in GK rats (46). 

Phrase: "This"

Phrase: "may"

Phrase: "be"

Phrase: "related to reduced generation of acetyl-CoA"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0079411:Generation [Temporal Concept]
   748   C0392756:Reduced [Qualitative Concept]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C3146294:Generation [Activity]
   714 E C0163712:Relate [Organic Chemical]

Phrase: "from KIC"

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of defective decarboxylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011094:Decarboxylation [Natural Phenomenon or Process]

Phrase: "of this ketoacid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022618:Ketoacid [Organic Chemical]

Phrase: "by the mitochondrial BCKDH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   895   C0046494:Branched Chain Ketoacid Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in GK rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.159: However, because Niddm1i islets respond normally to KIC, the genetic defect for the impaired insulin response to KIC in GK islets is unlikely to be related to Niddm1i and, according to syntenic conservation, the BCKDH genes are not located in the Niddm1i region. 

Phrase: "However,"

Phrase: "because"

Phrase: "Niddm1i islets"

Phrase: "respond"

Phrase: "normally to KIC,"

Phrase: "the genetic defect for the impaired insulin response to KIC"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   739   C0314603:Genetic [Functional Concept]
   739   C1457869:Defect [Functional Concept]
   739   C1861101:DEFECT [Disease or Syndrome]
   732   C0000768:Birth Defect [Congenital Abnormality]
   732   C1737329:Birth defect [Congenital Abnormality]

Phrase: "in GK islets"

Phrase: "is"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "be"

Phrase: "related to Niddm1i"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0439849:Related [Qualitative Concept]
   790   C0445223:Related [Finding]
   756 E C0163712:Relate [Organic Chemical]

Phrase: "and"

Phrase: ","

Phrase: "according to syntenic conservation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0969701:Syntenic Conservation [Molecular Function]
   861   C2347858:Conservation [Qualitative Concept]

Phrase: "the BCKDH genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0017337:Genes [Gene or Genome]
   728   C0046494:Branched Chain Ketoacid Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "located in the Niddm1i region."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
Processing 00000000.tx.160: In type 2 diabetes, not only are the plasma insulin levels decreased, but also the release kinetics of the hormone are affected. 

Phrase: "In type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "are"

Phrase: "the plasma insulin levels"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   966   C1276042:Plasma insulin level [Laboratory Procedure]
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   901   C0857690:plasma insulin [Laboratory Procedure]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "but"

Phrase: "also"

Phrase: "the release kinetics of the hormone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0022702:Kinetics [Natural Phenomenon or Process]
   753   C0220865:kinetics [Functional Concept]
   753   C2825046:Kinetics [Occupation or Discipline]

Phrase: "are"

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.161: Regular plasma insulin oscillations, which are present in normal individuals (47), are replaced by an irregular plasma insulin pattern (48). 

Phrase: "Regular plasma insulin oscillations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0695434:oscillations [Therapeutic or Preventive Procedure]
   708   C0021641:Insulin, Regular [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "which"

Phrase: "are"

Phrase: "present in normal individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "(47"

Phrase: ")"

Phrase: ","

Phrase: "are"

Phrase: "replaced by an irregular plasma insulin pattern"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0857690:plasma insulin [Laboratory Procedure]
   778   C1299987:Replaced by [Functional Concept]
           replaced
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0032105:Plasma [Body Substance]
   748   C0205271:Irregular [Qualitative Concept]
   748   C0449774:Pattern [Spatial Concept]
   748   C0559956:Replaced [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C1554078:Replace [Idea or Concept]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.162: The glucose-lowering effect of insulin depends on the release kinetics of the hormone (49,50). 

Phrase: "The glucose-lowering effect of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158774:glucose effect [Genetic Function]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "depends on the release kinetics of the hormone"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0019932:Hormone [Hormone]
   744   C0022702:Kinetics [Natural Phenomenon or Process]
   744   C0030685:Release [Health Care Activity]
   744   C0220865:kinetics [Functional Concept]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C0725813:depend [Medical Device]
   744   C1283071:Release [Functional Concept]
   744   C1963578:Release [Therapeutic or Preventive Procedure]
   744   C2825046:Kinetics [Occupation or Discipline]

Phrase: "(49,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.163: The disturbed plasma hormone pattern observed in patients with type 2 diabetes (48) has been connected with the downregulation of insulin receptors (51). 

Phrase: "The disturbed plasma hormone pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449774:Pattern [Spatial Concept]

Phrase: "observed in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1441672:Observed [Functional Concept]

Phrase: "with type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(48"

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "connected with the downregulation of insulin receptors"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   757   C0949469:Receptor Down-Regulation [Molecular Function]
   748   C0013081:Down-Regulation [Cell Function,Molecular Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   745 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   714   C2986575:Connect [Activity]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.164: It has been speculated that the disturbed plasma insulin pattern may be caused by loss of pulsatile release from the -cell (26). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "speculated"

Phrase: "that"

Phrase: "the disturbed plasma insulin pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449774:Pattern [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "caused by loss of pulsatile release"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0439606:Pulsatile [Temporal Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1517945:Loss [Quantitative Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
   719   C0015127:cause [Functional Concept]
   719   C1524003:Cause [Conceptual Entity]

Phrase: "from the -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.165: The present results, that pulsatile insulin release from control F344 islets is comparable with regard to frequency to that observed from GK and the congenic islets, make this speculation less plausible. 

Phrase: "The present results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "that pulsatile insulin release from control F344 islets"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0030685:Release [Health Care Activity]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "comparable with regard to frequency"

Phrase: "to that"

Phrase: "observed from GK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "the congenic islets,"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "this speculation"

Phrase: "less plausible"

Phrase: "."
Processing 00000000.tx.166: Instead, less regular plasma insulin oscillations may be caused by the decrease in glucose-induced insulin release manifested as a reduction of the amplitude of the insulin pulses (52). 

Phrase: "Instead,"

Phrase: "less regular plasma insulin oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "caused by the decrease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "in glucose-induced insulin release"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1963578:Release [Therapeutic or Preventive Procedure]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "manifested as a reduction of the amplitude of the insulin pulses"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0034107:Pulses [Health Care Activity]
   738   C0205319:manifested [Functional Concept]
   738   C0301630:Reduction [Natural Phenomenon or Process]
   738   C0391850:PULSES [Physiologic Function]
   738   C0392756:Reduction [Qualitative Concept]
   738   C0441610:Reduction [Therapeutic or Preventive Procedure]
   738   C1280444:manifested [Qualitative Concept]
   738   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1579433:Insulin [Pharmacologic Substance]
   738   C2346753:Amplitude [Spatial Concept]
   704 E C0232117:PULSE [Clinical Attribute]
   704 E C1947910:Pulse [Phenomenon or Process]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.167: In summary, genes that influence stimulus secretion coupling have been located to the chromosome region encompassed by the Niddm1i locus. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "influence"

Phrase: "stimulus secretion coupling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1948027:Coupling [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "located to the chromosome region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1953345:Chromosome region [Cell]
   760   C0008633:Chromosome [Cell Component]
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: "encompassed by the Niddm1i locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.168: High-resolution genetic mapping of the locus in combination with whole-animal and islet functional studies will provide unique opportunities to locate and study susceptibility genes involved in the cause of impaired insulin secretion in diabetes.  

Phrase: "High-resolution genetic mapping of the locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0008630:genetic mapping [Laboratory Procedure,Molecular Biology Research Technique]
   748   C1283195:Mapping [Activity]

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with whole-animal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0229961:Whole Animal [Fully Formed Anatomical Structure]
   861   C0003062:Animal [Animal]

Phrase: "and"

Phrase: "islet functional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "will"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "unique opportunities to"

Phrase: "locate"

Phrase: "and"

Phrase: "study susceptibility genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0919453:Susceptibility Gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "involved in the cause of impaired insulin secretion"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C1256369:insulin secretion [Cell Function]
   744   C0015127:cause [Functional Concept]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C0221099:Impaired [Functional Concept]
   744   C0684336:Impaired [Pathologic Function]
   744   C1314939:Involved [Functional Concept]
   744   C1524003:Cause [Conceptual Entity]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.169: ACKNOWLEDGMENTS  The study was supported by grants from the Swedish Medical Research Council (72X-14019, 9109, and 12202), the Swedish Diabetes Association, the Novo Nordisk Foundation, the Family Ernfors Foundation, the Marcus and Amalia Wallenberg Foundation, the Swedish Foundation for Strategic Research, the Magnus Bergvalls Foundation, the Swedish Society of Medicine, and the Gran Gustafsson Foundation.  

Phrase: "ACKNOWLEDGMENTS"

Phrase: "The study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Swedish Medical Research Council"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0079816:Medical Research [Research Activity]
   861   C1556038:Medical Research [Professional or Occupational Group]
   812   C0035168:research [Research Activity]
   812   C0205476:Medical [Functional Concept]
   812   C0242481:Research [Research Activity]
   812   C1551807:Council [Population Group]

Phrase: "(72X-14019,"

Phrase: "9109,"

Phrase: "and"

Phrase: "12202"

Phrase: ")"

Phrase: ","

Phrase: "the Swedish Diabetes Association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "the Novo Nordisk Foundation,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   734   C0331875:Novo Nordisk [Health Care Related Organization]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "the Family Ernfors Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "the Marcus"

Phrase: "and"

Phrase: "Amalia Wallenberg Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "the Swedish Foundation for Strategic Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0016617:Foundation [Organization]
   742   C2986512:Research Base [Organization]

Phrase: "the Magnus Bergvalls Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "the Swedish Society of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0037455:society [Organization]

Phrase: "and"

Phrase: "the Gran Gustafsson Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.170: FOOTNOTES  Address correspondence and reprint requests to Dr. 

Phrase: "FOOTNOTES  Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Dr."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0031831:DR [Professional or Occupational Group]
   790   C0686900:request [Functional Concept]
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.171: Peter Bergsten, Department of Medical Cell Biology, Uppsala University, Box 571, SE-751 23 Uppsala, Sweden. 

Phrase: "Peter Bergsten,"

Phrase: "Department of Medical Cell Biology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0587450:Medical department [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "Uppsala University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Box 571,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "SE-751 23 Uppsala,"

Phrase: "Sweden."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]
Processing 00000000.tx.172: E-mail: peter.bergsten{at}medcellbiol.uu.se . Received for publication 19 April 2001 and accepted in revised form 11 September 2001. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "peter.bergsten{at}medcellbiol.uu.se ."

Phrase: "Received for publication 19 April 2001"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034036:Publication [Intellectual Product,Manufactured Object]
   753   C0034037:Publication [Occupational Activity]
   753   C1514756:Received [Qualitative Concept]
   753   C1704324:Publication [Intellectual Product]

Phrase: "and"

Phrase: "accepted in revised form 11 September 2001."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1527075:Revised [Therapeutic or Preventive Procedure]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.173: H.L. is a consultant for Arexis and Gemini Genomics and receives grant support from and is on the board of directors of Arexis. 

Phrase: "H.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346686:h l [Quantitative Concept]

Phrase: "is"

Phrase: "a consultant for Arexis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0009817:Consultant [Professional or Occupational Group]
   770   C1549076:consultant [Idea or Concept]

Phrase: "and"

Phrase: "Gemini Genomics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "receives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Receive [Qualitative Concept]

Phrase: "grant support from"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0183683:Support [Medical Device]
   790   C1521721:Support [Conceptual Entity]

Phrase: "and"

Phrase: "is on the board of directors of Arexis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0972401:board [Medical Device]
   744   C1948070:Board [Organization]
Processing 00000000.tx.174: H.L. holds stock in Arexis, Gemini Genomics, and AstraZeneca. 

Phrase: "H.L. holds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1553387:Hold [Idea or Concept]
   793   C1948035:Hold [Activity]
   734   C2346686:h l [Quantitative Concept]

Phrase: "stock in Arexis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1710198:Stock [Idea or Concept]

Phrase: "Gemini Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "AstraZeneca."
Processing 00000000.tx.175: BCKDH, branched-chain 2-ketoacid dehydrogenase; 

Phrase: "BCKDH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   924   C0046494:Branched Chain Ketoacid Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "branched-chain 2-ketoacid dehydrogenase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   924   C0046494:Branched Chain Ketoacid Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.176: BSA, bovine serum albumin; 

Phrase: "BSA,"

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.177: KIC, -ketoisocaproate; 

Phrase: "KIC, -"

Phrase: "ketoisocaproate"

Phrase: ";"
Processing 00000000.tx.178: QTL, quantitative trait locus.  

Phrase: "QTL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597336:QTL [Gene or Genome]

Phrase: "quantitative trait locus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597336:quantitative trait locus [Gene or Genome]
   827   C0392762:Quantitative [Quantitative Concept]
   827   C0599883:Trait [Organism Attribute]
   827   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.179: REFERENCES TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Barnett AH, Eff C, Leslie RD, Pyke DA: Diabetes in identical twins: a study of 200 pairs. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Barnett AH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1836672:AH [Disease or Syndrome]

Phrase: "Eff"

Phrase: "C,"

Phrase: "Leslie RD,"

Phrase: "Pyke DA"

Phrase: ":"

Phrase: "Diabetes in identical twins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "a study of 200 pairs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
Processing 00000000.tx.180: Diabetologia 20:8793, 1981[Medline] Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD: Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. 

Phrase: "Diabetologia 20"

Phrase: ":"

Phrase: "8793,"

Phrase: "1981"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Newman B,"

Phrase: "Selby JV,"

Phrase: "King"

Phrase: "MC,"

Phrase: "Slemenda C,"

Phrase: "Fabsitz R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Friedman GD"

Phrase: ":"

Phrase: "Concordance for type 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680240:concordance [Social Behavior]

Phrase: "(non-insulin-dependent) diabetes mellitus in male twins."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   869   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
   869   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   833   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   770   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1518422:Non [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]
Processing 00000000.tx.181: Diabetologia 30:763768, 1987[Medline] Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H: Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerancea population-based twin study. 

Phrase: "Diabetologia 30"

Phrase: ":"

Phrase: "763768,"

Phrase: "1987"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Poulsen P,"

Phrase: "Kyvik KO,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416746:KO [Gene or Genome]
   861   C1862225:Ko [Body System]

Phrase: "Vaag A,"

Phrase: "Beck-Nielsen H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Heritability of type II"

Phrase: "(non-insulin-dependent) diabetes mellitus"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "abnormal glucose tolerancea population-based twin study."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   852   C1709599:Population Based Study [Research Activity]
   845   C0681876:Population Study [Research Activity]
   818   C0282476:twin study [Research Activity]
   818   C1096782:Twin Study [Intellectual Product]
   795   C0557651:Study [Manufactured Object]
   795   C2603343:Study [Research Activity]
Processing 00000000.tx.182: Diabetologia 42:139145, 1999[Medline] Ghosh S, Schork NJ: Genetic analysis of NIDDM: the study of quantitative traits. 

Phrase: "Diabetologia 42"

Phrase: ":"

Phrase: "139145,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ghosh S,"

Phrase: "Schork NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: ":"

Phrase: "Genetic analysis of NIDDM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0679560:genetic analysis [Laboratory Procedure]
   833   C0796344:Genetic Analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: ":"

Phrase: "the study of quantitative traits."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
Processing 00000000.tx.183: Diabetes 45:114, 1996[Abstract] Turner RC, Hattersley AT, Shaw JT, Levy JC: Type II diabetes: clinical aspects of molecular biological studies. 

Phrase: "Diabetes 45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "114,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Turner RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Hattersley AT,"

Phrase: "Shaw JT,"

Phrase: "Levy JC"

Phrase: ":"

Phrase: "Type II diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type II [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "clinical aspects of molecular biological studies."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0683325:clinical aspects [Clinical Attribute]
   719   C1547011:Aspect [Quantitative Concept]
   719   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.184: Diabetes 44:110, 1995[Abstract] Galli J, Li LS, Glaser A, Ostenson CG, Jiao H, Fakhrai-Rad H, Jacob HJ, Lander ES, Luthman H: Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. 

Phrase: "Diabetes 44"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "110,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Galli J,"

Phrase: "Li LS,"

Phrase: "Glaser A,"

Phrase: "Ostenson CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "Jiao H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Fakhrai-Rad H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Jacob HJ,"

Phrase: "Lander ES,"

Phrase: "Luthman H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Genetic analysis of non-insulin dependent diabetes mellitus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0679560:genetic analysis [Laboratory Procedure]
   770   C0796344:Genetic Analysis [Laboratory Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   703   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
   703   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]

Phrase: "in the GK rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
Processing 00000000.tx.185: Nat Genet 12:3137, 1996[Medline] Gauguier D, Froguel P, Parent V, Bernard C, Bihoreau MT, Portha B, James MR, Penicaud L, Lathrop M, Ktorza A: Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat. 

Phrase: "Nat Genet 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "3137,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gauguier D,"

Phrase: "Froguel P,"

Phrase: "Parent V,"

Phrase: "Bernard C,"

Phrase: "Bihoreau MT,"

Phrase: "Portha B,"

Phrase: "James MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Penicaud L,"

Phrase: "Lathrop M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ktorza A"

Phrase: ":"

Phrase: "Chromosomal mapping of genetic loci"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0008630:genetic mapping [Laboratory Procedure,Molecular Biology Research Technique]
           Chromosome Mapping
   760   C1283195:Mapping [Activity]

Phrase: "associated with non-insulin dependent diabetes"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   882   C0011860:Non-Insulin Dependent Diabetes [Disease or Syndrome]
   833   C0011854:Insulin Dependent Diabetes [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1518422:Non [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the GK rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
Processing 00000000.tx.186: Nat Genet 12:3843, 1996[Medline] Chung WK, Zheng M, Chua M, Kershaw E, Power-Kehoe L, Tsuji M, Wu-Peng XS, Williams J, Chua SC Jr, Leibel RL: Genetic modifiers of Leprfa associated with variability in insulin production and susceptibility to NIDDM. 

Phrase: "Nat Genet 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "3843,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chung WK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/wk [Temporal Concept]
   861   C0439230:wk [Temporal Concept]

Phrase: "Zheng M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Chua M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kershaw E,"

Phrase: "Power-Kehoe L,"

Phrase: "Tsuji M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wu-Peng XS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1421550:XS [Gene or Genome]

Phrase: "Williams J,"

Phrase: "Chua SC Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Leibel RL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: ":"

Phrase: "Genetic modifiers of Leprfa"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0205349:Modifier [Qualitative Concept]
   737   C1514623:Modifier [Conceptual Entity]
   737   C1516451:Modifier [Chemical Viewed Functionally]
   737   C3542952:Modifier [Intellectual Product]

Phrase: "associated with variability"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C2827666:Variability [Conceptual Entity]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C0439828:Variable [Qualitative Concept]

Phrase: "in insulin production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "susceptibility to NIDDM."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0012655:Susceptibility [Clinical Attribute]
   790   C0220898:Susceptibility [Organism Attribute]
   790   C1264642:Susceptibility [Functional Concept]
   790   C1547045:*Susceptibility [Quantitative Concept]
   718 E C0231204:Susceptible [Functional Concept]
   718 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]
Processing 00000000.tx.187: Genomics 41:332344, 1997[Medline] Watanabe TK, Ono T, Okuno S, Mizoguchi-Miyakita A, Yamasaki Y, Kanemoto N, Hishigaki H, Oga K, Takahashi E, Irie Y: Characterization of newly developed SSLP markers for the rat. 

Phrase: "Genomics 41"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: ":"

Phrase: "332344,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Watanabe TK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220928:TK [Geographic Area]

Phrase: "Ono T,"

Phrase: "Okuno S,"

Phrase: "Mizoguchi-Miyakita A,"

Phrase: "Yamasaki Y,"

Phrase: "Kanemoto N,"

Phrase: "Hishigaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Oga K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Takahashi E,"

Phrase: "Irie Y"

Phrase: ":"

Phrase: "Characterization of newly developed SSLP markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "for the rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]
Processing 00000000.tx.188: Mamm Genome 11:300305, 2000[Medline] Kanemoto N, Hishigaki H, Miyakita A, Oga K, Okuno S, Tsuji A, Takagi T, Takahashi E, Nakamura Y, Watanabe TK: Genetic dissection of "OLETF", a rat model for non-insulin-dependent diabetes mellitus. 

Phrase: "Mamm Genome 11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017428:Genome [Gene or Genome]
   827   C2338314:Genome [Conceptual Entity]

Phrase: ":"

Phrase: "300305,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kanemoto N,"

Phrase: "Hishigaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Miyakita A,"

Phrase: "Oga K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Okuno S,"

Phrase: "Tsuji A,"

Phrase: "Takagi T,"

Phrase: "Takahashi E,"

Phrase: "Nakamura Y,"

Phrase: "Watanabe TK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220928:TK [Geographic Area]

Phrase: ":"

Phrase: "Genetic dissection of ""OLETF"","

Phrase: "a rat model for non-insulin-dependent diabetes mellitus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3161035:Model [Intellectual Product]
Processing 00000000.tx.189: Mamm Genome 9:419425, 1998[Medline] Hirayama I, Yi Z, Izumi S, Arai I, Suzuki W, Nagamachi Y, Kuwano H, Takeuchi T, Izumi T: Genetic analysis of obese diabetes in the TSOD mouse. 

Phrase: "Mamm Genome 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017428:Genome [Gene or Genome]
   827   C2338314:Genome [Conceptual Entity]

Phrase: ":"

Phrase: "419425,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hirayama I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Yi Z,"

Phrase: "Izumi S,"

Phrase: "Arai I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Suzuki W,"

Phrase: "Nagamachi Y,"

Phrase: "Kuwano H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Takeuchi T,"

Phrase: "Izumi T"

Phrase: ":"

Phrase: "Genetic analysis of obese diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0679560:genetic analysis [Laboratory Procedure]
   806   C0796344:Genetic Analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in the TSOD mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]
Processing 00000000.tx.190: Diabetes 48:11831191, 1999[Abstract] Ueda H, Ikegami H, Kawaguchi Y, Fujisawa T, Yamato E, Shibata M, Ogihara T: Genetic analysis of late-onset type 2 diabetes in a mouse model of human complex trait. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "11831191,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ueda H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ikegami H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kawaguchi Y,"

Phrase: "Fujisawa T,"

Phrase: "Yamato E,"

Phrase: "Shibata M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ogihara T"

Phrase: ":"

Phrase: "Genetic analysis of late-onset type 2 diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0679560:genetic analysis [Laboratory Procedure]
   770   C0796344:Genetic Analysis [Laboratory Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "in a mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "of human complex trait."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0599883:Trait [Organism Attribute]
Processing 00000000.tx.191: Diabetes 48:11681174, 1999[Abstract] Suto J, Matsuura S, Imamura K, Yamanaka H, Sekikawa K: Genetic analysis of non-insulin-dependent diabetes mellitus in KK and KK-Ay mice. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "11681174,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Suto J,"

Phrase: "Matsuura S,"

Phrase: "Imamura K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yamanaka H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Sekikawa K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "Genetic analysis of non-insulin-dependent diabetes mellitus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0679560:genetic analysis [Laboratory Procedure]
   770   C0796344:Genetic Analysis [Laboratory Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   703   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
   703   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]

Phrase: "in KK"

Phrase: "and"

Phrase: "KK-Ay mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.192: Eur J Endocrinol 139:654661, 1998[Medline] Goto Y, Kakizaki M, Masaki N: Spontaneous diabetes produced by selective breeding of normal Wistar rats. 

Phrase: "Eur J Endocrinol 139"

Phrase: ":"

Phrase: "654661,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Goto Y,"

Phrase: "Kakizaki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Masaki N"

Phrase: ":"

Phrase: "Spontaneous diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "produced by selective breeding of normal Wistar rats."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0034716:Rats, Wistar [Mammal]
   770   C0678952:selective breeding [Genetic Function]
   744   C0006159:Breeding [Organism Function]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205307:Normal [Qualitative Concept]
   744   C0439166:% normal [Quantitative Concept]
   744   C2347086:% Normal [Quantitative Concept]
   744   C2700262:Wistar [Mammal]
Processing 00000000.tx.193: Proc Jpn Acad 51:8085, 1975 Goto Y, Kakizaki M: The spontaneous-diabetes rat: a model of noninsulin dependent diabetes mellitus. 

Phrase: "Proc Jpn Acad 51"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0022341:JPN [Geographic Area]
   812   C0268596:ACAD [Disease or Syndrome]
   812   C1418943:PROC [Gene or Genome]
   812   C2700624:ACAD [Cell Function]

Phrase: ":"

Phrase: "8085,"

Phrase: "1975 Goto Y,"

Phrase: "Kakizaki M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "The spontaneous-diabetes rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]

Phrase: ":"

Phrase: "a model of noninsulin dependent diabetes mellitus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.194: Proc Jpn Acad 57:381384, 1981 Goto Y, Suzuki K, Ono T, Sasaki M, Toyota T: Development of diabetes in the non-obese NIDDM rat (GK rat). 

Phrase: "Proc Jpn Acad 57"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0022341:JPN [Geographic Area]
   812   C0268596:ACAD [Disease or Syndrome]
   812   C1418943:PROC [Gene or Genome]
   812   C2700624:ACAD [Cell Function]

Phrase: ":"

Phrase: "381384,"

Phrase: "1981 Goto Y,"

Phrase: "Suzuki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ono T,"

Phrase: "Sasaki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Toyota T"

Phrase: ":"

Phrase: "Development of diabetes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "in the non-obese NIDDM rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]

Phrase: "(GK rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]

Phrase: ")."
Processing 00000000.tx.195: Adv Exp Med Biol 246:2931, 1988[Medline] Galli J, Fakhrai-Rad H, Kamel A, Marcus C, Norgren S, Luthman H: Pathophysiological and genetic characterization of the major diabetes locus in GK rats. 

Phrase: "Adv Exp Med Biol 246"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0001483:ADV [Virus]
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "2931,"

Phrase: "1988"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Galli J,"

Phrase: "Fakhrai-Rad H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Kamel A,"

Phrase: "Marcus C,"

Phrase: "Norgren S,"

Phrase: "Luthman H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Pathophysiological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0031847:pathophysiology [Functional Concept]
   928   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "and"

Phrase: "genetic characterization of the major diabetes locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]

Phrase: "in GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.196: Diabetes 48:24632470, 1999[Abstract] Fakhrai-Rad H, Nikoshkov A, Kamel A, Fernstrom M, Zierath JR, Norgren S, Luthman H, Galli J: Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "24632470,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Fakhrai-Rad H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Nikoshkov A,"

Phrase: "Kamel A,"

Phrase: "Fernstrom M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zierath JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Norgren S,"

Phrase: "Luthman H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Galli J"

Phrase: ":"

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "identified as a candidate diabetes susceptibility gene"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0919453:Susceptibility Gene [Gene or Genome]
   774   C1332838:Candidate Gene [Gene or Genome]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0012655:Susceptibility [Clinical Attribute]
   748   C0017337:Gene [Gene or Genome]
   748   C0205396:Identified [Qualitative Concept]
   748   C0220898:Susceptibility [Organism Attribute]
   748   C1264642:Susceptibility [Functional Concept]
   748   C1547045:*Susceptibility [Quantitative Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]

Phrase: "in GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.197: Hum Mol Genet 9:21492158, 2000[Abstract/Free FullText] Bergsten P, Hellman B: Glucose-induced amplitude regulation of pulsatile insulin secretion from individual pancreatic islets. 

Phrase: "Hum Mol Genet 9"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "21492158,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bergsten P,"

Phrase: "Hellman B"

Phrase: ":"

Phrase: "Glucose-induced amplitude regulation of pulsatile insulin secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1325895:regulation of insulin secretion [Cell Function]
   793   C1523071:regulation of secretion [Cell Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "from individual pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.198: Diabetes 42:670674, 1993[Abstract] Sykes JA, Moore EB: A new chamber for tissue culture. 

Phrase: "Diabetes 42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "670674,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sykes JA,"

Phrase: "Moore EB"

Phrase: ":"

Phrase: "A new chamber for tissue culture."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0935616:Chamber [Body Part, Organ, or Organ Component]
Processing 00000000.tx.199: Proc Soc Exp Biol Med 100:125127, 1959 Revsbech NP: An oxygen microsensor with a guard cathode. 

Phrase: "Proc Soc Exp Biol Med 100"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1417055:EXP [Gene or Genome]
   799   C1418943:PROC [Gene or Genome]

Phrase: ":"

Phrase: "125127,"

Phrase: "1959 Revsbech NP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706141:NP [Gene or Genome]

Phrase: ":"

Phrase: "An oxygen microsensor with a guard cathode."
Processing 00000000.tx.200: Limnol Oceanogr 34:474478, 1989 Ortster H, Liss P, Lund PE, kerman KEO, Bergsten P: Oscillations in oxygen tension and insulin release of individual pancreatic ob/ob mouse islets. 

Phrase: "Limnol Oceanogr 34"

Phrase: ":"

Phrase: "474478,"

Phrase: "1989 Ortster H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Liss P,"

Phrase: "Lund PE,"

Phrase: "kerman KEO,"

Phrase: "Bergsten P"

Phrase: ":"

Phrase: "Oscillations in oxygen tension"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "insulin release of individual pancreatic ob/ob mouse islets."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0030685:Release [Health Care Activity]
   742   C0391871:Release [Functional Concept]
   742   C0439180:% release [Quantitative Concept]
   742   C0680255:release [Health Care Activity]
   742   C1283071:Release [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.201: Diabetologia 43:13131318, 2000[Medline] Goto Y, Suzuki KI, Sasaki M, Ono T, Abe S: GK rat as a model of nonobese, noninsulin-dependent diabetes: selective breeding over 35 generations. 

Phrase: "Diabetologia 43"

Phrase: ":"

Phrase: "13131318,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Goto Y,"

Phrase: "Suzuki KI,"

Phrase: "Sasaki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ono T,"

Phrase: "Abe S"

Phrase: ":"

Phrase: "GK rat as a model of nonobese, noninsulin-dependent diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0034693:Rat, NOS [Mammal]
   739   C0034721:Rat [Mammal]

Phrase: ":"

Phrase: "selective breeding over 35 generations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0678952:selective breeding [Genetic Function]
   760   C0006159:Breeding [Organism Function]
Processing 00000000.tx.202: In Frontiers in Diabetes Research. 

Phrase: "In Frontiers"

Phrase: "in Diabetes Research."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
Processing 00000000.tx.203: Lessons From Animal Diabetes II. 

Phrase: "Lessons From Animal Diabetes II."
Processing 00000000.tx.204: Shafrir AER, Ed. 

Phrase: "Shafrir AER,"

Phrase: "Ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]
Processing 00000000.tx.205: John Libbey & Company, 1988, p. 

Phrase: "John Libbey & Company,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683757:Company [Manufactured Object,Organization]

Phrase: "1988,"

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.206: 301303 Abdel-Halim SM, Guenifi A, Efendic S, Ostenson CG: Both somatostatin and insulin responses to glucose are impaired in the perfused pancreas of the spontaneously noninsulin-dependent diabetic GK (Goto-Kakizaki) rats. 

Phrase: "301303 Abdel-Halim SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036154:SM [Geographic Area]

Phrase: "Guenifi A,"

Phrase: "Efendic S,"

Phrase: "Ostenson CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: ":"

Phrase: "Both somatostatin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   916 E C0373723:somatostatins [Laboratory Procedure]

Phrase: "and"

Phrase: "insulin responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "are"

Phrase: "impaired in the perfused pancreas"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   726   C1549542:Perfuse [Functional Concept]

Phrase: "of the spontaneously noninsulin-dependent diabetic GK (Goto-Kakizaki) rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0034693:rats [Mammal]
   793   C0034721:Rats [Mammal]
Processing 00000000.tx.207: Acta Physiol Scand 148:219226, 1993[Medline] Bergsten P, Hellman B: Glucose inhibits insulin release when not promoting the entry of calcium into the beta-cells. 

Phrase: "Acta Physiol Scand 148"

Phrase: ":"

Phrase: "219226,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bergsten P,"

Phrase: "Hellman B"

Phrase: ":"

Phrase: "Glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "when"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "the entry of calcium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705654:Entry [Intellectual Product]

Phrase: "into the beta-cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   966   C0030281:Beta cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.208: Biochem Biophys Res Commun 125:875881, 1984[Medline] Hellman B, Berne C, Grapengiesser E, Grill V, Gylfe E, Lund PE: The cytoplasmic Ca2+ response to glucose as an indicator of impairment of the pancreatic beta-cell function. 

Phrase: "Biochem Biophys Res Commun 125"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "875881,"

Phrase: "1984"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hellman B,"

Phrase: "Berne C,"

Phrase: "Grapengiesser E,"

Phrase: "Grill V,"

Phrase: "Gylfe E,"

Phrase: "Lund PE"

Phrase: ":"

Phrase: "The cytoplasmic Ca2+ response to glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "as an indicator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
  1000   C1235732:Indicator [Bird]
  1000   C1522602:Indicator [Functional Concept]

Phrase: "of impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0684336:Impairment [Pathologic Function]

Phrase: "of the pancreatic beta-cell function."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   902   C0232786:Pancreatic function [Organ or Tissue Function]
   861   C0007613:Cell Function [Cell Function]
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   756   C0030281:Pancreatic beta cell [Cell]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.209: Eur J Clin Invest 20 (Suppl. 1):S10S17, 1990 Ostenson CG, Khan A, Abdel-Halim SM, Guenifi A, Suzuki K, Goto Y, Efendic S: Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat. 

Phrase: "Eur J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "20"

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "S10S17,"

Phrase: "1990 Ostenson CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   827   C3540479:CG [Gene or Genome]

Phrase: "Khan A,"

Phrase: "Abdel-Halim SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036154:SM [Geographic Area]

Phrase: "Guenifi A,"

Phrase: "Suzuki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Goto Y,"

Phrase: "Efendic S"

Phrase: ":"

Phrase: "Abnormal insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   913   C0679330:abnormal secretion [Pathologic Function]
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucose metabolism in pancreatic islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0596620:glucose metabolism [Molecular Function]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: "from the spontaneously diabetic GK rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]
Processing 00000000.tx.210: Diabetologia 36:38, 1993[Medline] Giroix MH, Vesco L, Portha B: Functional and metabolic perturbations in isolated pancreatic islets from the GK rat, a genetic model of noninsulin-dependent diabetes. 

Phrase: "Diabetologia 36"

Phrase: ":"

Phrase: "38,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Giroix MH,"

Phrase: "Vesco L,"

Phrase: "Portha B"

Phrase: ":"

Phrase: "Functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "metabolic perturbations in isolated pancreatic islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0332453:perturbation [Functional Concept]

Phrase: "from the GK rat,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]

Phrase: "a genetic model of noninsulin-dependent diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0026343:Model, Genetic [Intellectual Product]
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.211: Endocrinology 132:815822, 1993[Abstract] Zhou YP, Ostenson CG, Ling ZC, Grill V: Deficiency of pyruvate dehydrogenase activity in pancreatic islets of diabetic GK rats. 

Phrase: "Endocrinology 132"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "815822,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Zhou YP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520214:Yp [Nucleotide Sequence]

Phrase: "Ostenson CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "Ling ZC,"

Phrase: "Grill V"

Phrase: ":"

Phrase: "Deficiency of pyruvate dehydrogenase activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   926   C0034345:Deficiency of pyruvate dehydrogenase [Disease or Syndrome]
           Pyruvate Dehydrogenase Deficiency
   844   C1291311:Deficiency of dehydrogenase [Disease or Syndrome]
           deficiency dehydrogenase
   844   C2936911:Pyruvate dehydrogenase deficiency [Disease or Syndrome]
   760   C0011155:Deficiency [Functional Concept]
   760   C0162429:Deficiency [Disease or Syndrome]
   760   C1623416:deficiency [Qualitative Concept]

Phrase: "in pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "of diabetic GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.212: Endocrinology 136:35463551, 1995[Abstract] Leckstrom A, Ostenson CG, Efendic S, Arnelo U, Permert J, Lundquist I, Westermark P: Increased storage and secretion of islet amyloid polypeptide relative to insulin in the spontaneously diabetic GK rat. 

Phrase: "Endocrinology 136"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "35463551,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Leckstrom A,"

Phrase: "Ostenson CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "Efendic S,"

Phrase: "Arnelo U,"

Phrase: "Permert J,"

Phrase: "Lundquist I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Westermark P"

Phrase: ":"

Phrase: "Increased storage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337174:Storage [Spatial Concept]
   861   C1698986:Storage [Functional Concept]
   861   C1753314:storage [Cell Component]

Phrase: "and"

Phrase: "secretion of islet amyloid polypeptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]

Phrase: "relative to insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "in the spontaneously diabetic GK rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]
Processing 00000000.tx.213: Pancreas 13:259267, 1996[Medline] Salehi A, Henningsson R, Mosen H, Ostenson CG, Efendic S, Lundquist I: Dysfunction of the islet lysosomal system conveys impairment of glucose- induced insulin release in the diabetic GK rat. 

Phrase: "Pancreas 13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   861   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "259267,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Salehi A,"

Phrase: "Henningsson R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Mosen H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ostenson CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "Efendic S,"

Phrase: "Lundquist I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "Dysfunction of the islet lysosomal system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031847:dysfunction [Functional Concept]
   753   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "conveys"

Phrase: "impairment of glucose- induced insulin release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0684336:Impairment [Pathologic Function]

Phrase: "in the diabetic GK rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
Processing 00000000.tx.214: Endocrinology 140:30453053, 1999[Abstract/Free FullText] Abdel-Halim SM, Guenifi A, Khan A, Larsson O, Berggren PO, Ostenson CG, Efendic S: Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP. 

Phrase: "Endocrinology 140"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "30453053,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Abdel-Halim SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036154:SM [Geographic Area]

Phrase: "Guenifi A,"

Phrase: "Khan A,"

Phrase: "Larsson O,"

Phrase: "Berggren PO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442027:PO [Spatial Concept]

Phrase: "Ostenson CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "Efendic S"

Phrase: ":"

Phrase: "Impaired coupling of glucose signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1948027:Coupling [Functional Concept]

Phrase: "to the exocytotic machinery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337076:machinery [Manufactured Object]

Phrase: "in diabetic GK rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: ":"

Phrase: "a defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1457869:Defect [Functional Concept]
  1000   C1861101:DEFECT [Disease or Syndrome]

Phrase: "ameliorated by cAMP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Processing 00000000.tx.215: Diabetes 45:934940, 1996[Abstract] Ostenson CG, Abdel-Halim SM, Rasschaert J, Malaisse-Lagae F, Meuris S, Sener A, Efendic S, Malaisse WJ: Deficient activity of FAD-linked glycerophosphate dehydrogenase in islets of GK rats. 

Phrase: "Diabetes 45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "934940,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ostenson CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "Abdel-Halim SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036154:SM [Geographic Area]

Phrase: "Rasschaert J,"

Phrase: "Malaisse-Lagae F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Meuris S,"

Phrase: "Sener A,"

Phrase: "Efendic S,"

Phrase: "Malaisse WJ"

Phrase: ":"

Phrase: "Deficient activity of FAD-linked glycerophosphate dehydrogenase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1151278:glycerophosphate dehydrogenase activity [Amino Acid, Peptide, or Protein,Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "in islets"

Phrase: "of GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.216: Diabetologia 36:722726, 1993[Medline] Koike G, Van Vooren P, Shiozawa M, Galli J, Li LS, Glaser A, Balasubramanyam A, Brown LJ, Luthman H, Szpirer C: Genetic mapping and chromosome localization of the rat mitochondrial glycerol-3-phosphate dehydrogenase gene, a candidate for non-insulin-dependent diabetes mellitus. 

Phrase: "Diabetologia 36"

Phrase: ":"

Phrase: "722726,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Koike G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Van Vooren P,"

Phrase: "Shiozawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Galli J,"

Phrase: "Li LS,"

Phrase: "Glaser A,"

Phrase: "Balasubramanyam A,"

Phrase: "Brown LJ,"

Phrase: "Luthman H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Szpirer C"

Phrase: ":"

Phrase: "Genetic mapping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008630:genetic mapping [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1283195:Mapping [Activity]

Phrase: "and"

Phrase: "chromosome localization of the rat mitochondrial glycerol-3-phosphate dehydrogenase gene,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C1657114:chromosome localisation [Biologic Function]
   754   C0008630:Gene Localization [Laboratory Procedure,Molecular Biology Research Technique]
   754   C1657244:mitochondrial localization [Biologic Function]
   738   C0475264:Localisation [Functional Concept]
   738   C1744691:localisation [Biologic Function]

Phrase: "a candidate for non-insulin-dependent diabetes mellitus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   703   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
   703   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
Processing 00000000.tx.217: Genomics 38:9699, 1996[Medline] Ueda K, Tanizawa Y, Ishihara H, Kizuki N, Ohta Y, Matsutani A, Oka Y: Overexpression of mitochondrial FAD-linked glycerol-3-phosphate dehydrogenase does not correct glucose-stimulated insulin secretion from diabetic GK rat pancreatic islets. 

Phrase: "Genomics 38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: ":"

Phrase: "9699,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ueda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Tanizawa Y,"

Phrase: "Ishihara H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kizuki N,"

Phrase: "Ohta Y,"

Phrase: "Matsutani A,"

Phrase: "Oka Y"

Phrase: ":"

Phrase: "Overexpression of mitochondrial FAD-linked glycerol-3-phosphate dehydrogenase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1514559:Overexpression [Genetic Function]

Phrase: "does"

Phrase: "not correct glucose-stimulated insulin secretion from diabetic GK rat pancreatic islets."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C1256369:insulin secretion [Cell Function]
   751   C0030296:Pancreatic Secretion [Body Substance]
   751   C0232787:Pancreatic secretion [Organ or Tissue Function]
   751   C0421248:diabetic insulin [Finding]
   751   C1719133:Glucose/Insulin [Quantitative Concept]
   736   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   736   C0036536:secretion [Biologic Function]
   736   C0036537:Secretion [Body Substance]
   736   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   736   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.218: Diabetologia 41:649653, 1998[Medline] Ling ZC, Efendic S, Wibom R, Abdel-Halim SM, Ostenson CG, Landau BR, Khan A: Glucose metabolism in Goto-Kakizaki rat islets. 

Phrase: "Diabetologia 41"

Phrase: ":"

Phrase: "649653,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ling ZC,"

Phrase: "Efendic S,"

Phrase: "Wibom R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Abdel-Halim SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036154:SM [Geographic Area]

Phrase: "Ostenson CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "Landau BR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704648:Br. [Conceptual Entity]

Phrase: "Khan A"

Phrase: ":"

Phrase: "Glucose metabolism in Goto-Kakizaki rat islets."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0596620:glucose metabolism [Molecular Function]
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.219: Endocrinology 139:26702675, 1998[Abstract/Free FullText] Hughes SJ, Faehling M, Thorneley CW, Proks P, Ashcroft FM, Smith PA: Electrophysiological and metabolic characterization of single beta-cells and islets from diabetic GK rats. 

Phrase: "Endocrinology 139"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "26702675,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hughes SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Faehling M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Thorneley CW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454665:CW [Geographic Area]

Phrase: "Proks P,"

Phrase: "Ashcroft FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Smith PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: ":"

Phrase: "Electrophysiological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0013865:Electrophysiology [Biomedical Occupation or Discipline]
   928   C1446476:Electrophysiology [Diagnostic Procedure]

Phrase: "and"

Phrase: "metabolic characterization of single beta-cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "islets from diabetic GK rats."
Processing 00000000.tx.220: Diabetes 47:7381, 1998[Abstract] Wang MY, Shimabukuro M, Lee Y, Trinh KY, Chen JL, Newgard CB, Unger RH: Adenovirus-mediated overexpression of uncoupling protein-2 in pancreatic islets of Zucker diabetic rats increases oxidative activity and improves beta-cell function. 

Phrase: "Diabetes 47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "7381,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wang"

Phrase: "MY,"

Phrase: "Shimabukuro M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lee Y,"

Phrase: "Trinh KY,"

Phrase: "Chen JL,"

Phrase: "Newgard CB,"

Phrase: "Unger RH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: ":"

Phrase: "Adenovirus-mediated overexpression of uncoupling protein-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "in pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "of Zucker diabetic rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "oxidative activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "improves"

Phrase: "beta-cell function."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   901   C0007613:Cell Function [Cell Function]
   901   C0030281:Beta cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0031843:function [Physiologic Function]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705273:Function [Intellectual Product]
   827   C1948049:Cell [Spatial Concept]
   827   C2004068:Beta [Qualitative Concept]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.221: Diabetes 48:10201025, 1999[Abstract] Chan CB, MacDonald PE, Saleh MC, Johns DC, Marban E, Wheeler MB: Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "10201025,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Chan CB,"

Phrase: "MacDonald PE,"

Phrase: "Saleh MC,"

Phrase: "Johns DC,"

Phrase: "Marban E,"

Phrase: "Wheeler MB"

Phrase: ":"

Phrase: "Overexpression of uncoupling protein 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "glucose-stimulated insulin secretion from rat islets."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1256369:insulin secretion [Cell Function]
   774   C1719133:Glucose/Insulin [Quantitative Concept]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.222: Diabetes 48:14821486, 1999[Abstract] Chan CB, De Leo D, Joseph JW, McQuaid TS, Ha XF, Xu F, Tsushima RG, Pennefather PS, Salapatek AM, Wheeler MB: Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "14821486,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Chan CB,"

Phrase: "De Leo D,"

Phrase: "Joseph JW,"

Phrase: "McQuaid TS,"

Phrase: "Ha XF,"

Phrase: "Xu F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Tsushima RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Pennefather PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Salapatek"

Phrase: "AM"

Phrase: ","

Phrase: "Wheeler MB"

Phrase: ":"

Phrase: "Increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "uncoupling protein-2 levels in beta-cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C0428479:Protein level [Laboratory or Test Result]
   757   C0456948:Level 2 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "associated with impaired glucose-stimulated insulin secretion"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1256369:insulin secretion [Cell Function]
   774   C1719133:Glucose/Insulin [Quantitative Concept]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0221099:Impaired [Functional Concept]
   748   C0684336:Impaired [Pathologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: ":"

Phrase: "mechanism of action."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031327:mechanism of action [Physiologic Function]
  1000   C1524059:mechanism of action [Functional Concept]
   790   C0441712:Mechanism [Functional Concept]
   790   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.223: Diabetes 50:13021310, 2001[Abstract/Free FullText] Trube G, Rorsman P, Ohno-Shosaku T: Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "13021310,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Trube G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Rorsman P,"

Phrase: "Ohno-Shosaku T"

Phrase: ":"

Phrase: "Opposite effects of tolbutamide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "diazoxide on the ATP-dependent K+ channel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]

Phrase: "in mouse pancreatic beta-cells."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   906   C1522214:Mouse Beta Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.224: Pflgers Arch 407:493499, 1986[Medline] Tsuura Y, Ishida H, Okamoto Y, Kato S, Sakamoto K, Horie M, Ikeda H, Okada Y, Seino Y: Glucose sensitivity of ATP-sensitive K+ channels is impaired in beta-cells of the GK rat: a new genetic model of NIDDM. 

Phrase: "Pflgers Arch 407"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "493499,"

Phrase: "1986"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tsuura Y,"

Phrase: "Ishida H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Okamoto Y,"

Phrase: "Kato S,"

Phrase: "Sakamoto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Horie M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ikeda H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Okada Y,"

Phrase: "Seino Y"

Phrase: ":"

Phrase: "Glucose sensitivity of ATP-sensitive K+ channels"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   757   C1547341:Channel sensitivity [Idea or Concept]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]

Phrase: "is"

Phrase: "impaired in beta-cells of the GK rat"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   744   C0007634:Cells [Cell]
   744   C0034693:Rat, NOS [Mammal]
   744   C0034721:Rat [Mammal]
   744   C0221099:Impaired [Functional Concept]
   744   C0330390:Beta [Plant]
   744   C0439096:Beta [Intellectual Product]
   744   C0684336:Impaired [Pathologic Function]
   744   C2004068:Beta [Qualitative Concept]
   744   C3282337:Cells [Cell]
   737   C0030281:Beta cell [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "a new genetic model of NIDDM."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026343:Model, Genetic [Intellectual Product]
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.225: Diabetes 42:14461453, 1993[Abstract] Lenzen S, Schmidt W, Rustenbeck I, Panten U: 2-Ketoglutarate generation in pancreatic B-cell mitochondria regulates insulin secretory action of amino acids and 2-keto acids. 

Phrase: "Diabetes 42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "14461453,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lenzen S,"

Phrase: "Schmidt W,"

Phrase: "Rustenbeck I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Panten U"

Phrase: ":"

Phrase: "2-Ketoglutarate generation in pancreatic B-cell mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0079411:Generation [Temporal Concept]
   744   C3146294:Generation [Activity]

Phrase: "regulates"

Phrase: "insulin secretory action of amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441472:Action [Functional Concept]
   753   C3266814:Action [Activity]

Phrase: "and"

Phrase: "2-keto acids."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0022618:Keto Acids [Organic Chemical]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.226: Biosci Rep 6:163169, 1986[Medline] Renstrom E, Eliasson L, Bokvist K, Rorsman P: Cooling inhibits exocytosis in single mouse pancreatic B-cells by suppression of granule mobilization. 

Phrase: "Biosci Rep 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1744664:REP [Molecular Function]

Phrase: ":"

Phrase: "163169,"

Phrase: "1986"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Renstrom E,"

Phrase: "Eliasson L,"

Phrase: "Bokvist K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Rorsman P"

Phrase: ":"

Phrase: "Cooling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0678568:cooling [Natural Phenomenon or Process]
   966 E C1548792:Cool [Qualitative Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "exocytosis in single mouse pancreatic B-cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C1519325:Single Cell Exocytosis [Cell Function]
   748   C0015283:Exocytosis [Cell Function]

Phrase: "by suppression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0221103:Suppression [Pathologic Function]
  1000   C0301625:Suppression [Organism Function]
  1000   C0439181:% suppression [Quantitative Concept]
  1000   C0728721:suppression [Mental Process]

Phrase: "of granule mobilization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   861   C0300926:mobilization [Functional Concept]
Processing 00000000.tx.227: J Physiol (Lond) 494:4152, 1996[Abstract] Eliasson L, Renstrom E, Ding WG, Proks P, Rorsman P: Rapid ATP-dependent priming of secretory granules precedes Ca2+-induced exocytosis in mouse pancreatic B-cells. 

Phrase: "J Physiol"

Phrase: "(Lond) 494"

Phrase: ":"

Phrase: "4152,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Eliasson L,"

Phrase: "Renstrom E,"

Phrase: "Ding WG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043092:WG [Disease or Syndrome]

Phrase: "Proks P,"

Phrase: "Rorsman P"

Phrase: ":"

Phrase: "Rapid ATP-dependent priming of secretory granules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0871133:Priming [Functional Concept]

Phrase: "precedes"

Phrase: "Ca2+-induced exocytosis in mouse pancreatic B-cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0015283:Exocytosis [Cell Function]
Processing 00000000.tx.228: J Physiol (Lond) 503:399412, 1997[Abstract] Giroix MH, Saulnier C, Portha B: Decreased pancreatic islet response to L-leucine in the spontaneously diabetic GK rat: enzymatic, metabolic and secretory data. 

Phrase: "J Physiol"

Phrase: "(Lond) 503"

Phrase: ":"

Phrase: "399412,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Giroix MH,"

Phrase: "Saulnier C,"

Phrase: "Portha B"

Phrase: ":"

Phrase: "Decreased pancreatic islet response to L-leucine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1523845:response to leucine [Organism Function]
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "in the spontaneously diabetic GK rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]

Phrase: ":"

Phrase: "enzymatic, metabolic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0311400:Metabolic [Functional Concept]
   861   C1524026:Metabolic [Cell Function]
   861   C2707259:Metabolic [Clinical Attribute]

Phrase: "and"

Phrase: "secretory data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.229: Diabetologia 42:965977, 1999[Medline] Goodner CJ, Walike BC, Koerker DJ, Ensinck JW, Brown AC, Chideckel EW, Palmer J, Kalnasy L: Insulin, glucagon, and glucose exhibit synchronous, sustained oscillations in fasting monkeys. 

Phrase: "Diabetologia 42"

Phrase: ":"

Phrase: "965977,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Goodner CJ,"

Phrase: "Walike BC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2984916:BC [Quantitative Concept]

Phrase: "Koerker DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Ensinck JW,"

Phrase: "Brown AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Chideckel EW,"

Phrase: "Palmer J,"

Phrase: "Kalnasy L"

Phrase: ":"

Phrase: "Insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "synchronous, sustained oscillations in fasting monkeys."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0695434:oscillations [Therapeutic or Preventive Procedure]
Processing 00000000.tx.230: Science 195:177179, 1977[Medline] Lang DA, Matthews DR, Burnett M, Turner RC: Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man. 

Phrase: "Science 195"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "177179,"

Phrase: "1977"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lang DA,"

Phrase: "Matthews DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Burnett M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Turner RC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: ":"

Phrase: "Brief, irregular oscillations of basal plasma insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "glucose concentrations in diabetic man."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   797   C0427743:concentrations glucose [Laboratory Procedure]
   797   C1287281:concentrations glucose [Laboratory or Test Result]
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.231: Diabetes 30:435439, 1981[Abstract] Matthews DR, Naylor BA, Jones RG, Ward GM, Turner RC: Pulsatile insulin has greater hypoglycemic effect than continuous delivery. 

Phrase: "Diabetes 30"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "435439,"

Phrase: "1981"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Matthews DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Naylor BA,"

Phrase: "Jones RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Ward GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Turner RC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: ":"

Phrase: "Pulsatile insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "greater hypoglycemic effect than continuous delivery."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C2936720:Hypoglycemic Effect [Physiologic Function]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.232: Diabetes 32:617621, 1983[Abstract] Paolisso G, Sgambato S, Torella R, Varricchio M, Scheen A, DOnofrio F, Lefebvre PJ: Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes. 

Phrase: "Diabetes 32"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "617621,"

Phrase: "1983"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Paolisso G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Sgambato S,"

Phrase: "Torella R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Varricchio M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Scheen A,"

Phrase: "DOnofrio F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lefebvre PJ"

Phrase: ":"

Phrase: "Pulsatile insulin delivery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011209:Delivery [Therapeutic or Preventive Procedure]
   827   C0559563:delivery [Finding]
   827   C1705822:Delivery [Activity]

Phrase: "is"

Phrase: "more efficient than continuous infusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442799:Efficient [Qualitative Concept]

Phrase: "in modulating islet cell function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0007613:Cell Function [Cell Function]
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "in normal subjects"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "patients with type 1 diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1550335:Patient type [Classification]
   760   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.233: J Clin Endocrinol Metab 66:12201226, 1988[Abstract] Goodner CJ, Sweet IR, Harrison HC Jr: Rapid reduction and return of surface insulin receptors after exposure to brief pulses of insulin in perifused rat hepatocytes. 

Phrase: "J Clin Endocrinol Metab 66"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "12201226,"

Phrase: "1988"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Goodner CJ,"

Phrase: "Sweet IR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022065:IR [Geographic Area]
   861   C0022071:Ir [Element, Ion, or Isotope]
   861   C0034818:IR [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "Harrison HC Jr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: ":"

Phrase: "Rapid reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "return of surface insulin receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332156:Return [Qualitative Concept]

Phrase: "after exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to brief pulses"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0444804:Brief pulse [Spatial Concept]
   861   C0034107:Pulses [Health Care Activity]
   861   C0391850:PULSES [Physiologic Function]
   827 E C0232117:PULSE [Clinical Attribute]
   827 E C1947910:Pulse [Phenomenon or Process]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in perifused rat hepatocytes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0227525:Hepatocytes [Cell]
   793 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.234: Diabetes 37:13161323, 1988[Abstract] Bergsten P: Pathophysiology of impaired pulsatile insulin release. 

Phrase: "Diabetes 37"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "13161323,"

Phrase: "1988"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bergsten P"

Phrase: ":"

Phrase: "Pathophysiology of impaired pulsatile insulin release."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031847:pathophysiology [Functional Concept]
   753   C0277785:Pathophysiology [Qualitative Concept]
Processing 00000000.tx.235: Diabetes Metab Res Rev 16:179191, 2000[Medline]

Phrase: "Diabetes Metab Res Rev 16"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C2347379:RES [Finding]
   804   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "179191,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

